{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:30:09Z","timestamp":1793917809030,"version":"4.8.0"},"reference-count":385,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0664-z","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T07:16:48Z","timestamp":1550215008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":273,"title":["A walk through tau therapeutic strategies"],"prefix":"10.1186","volume":"7","author":[{"given":"Santosh","family":"Jadhav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u00f6","family":"K\u00f6vari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rostislav","family":"Skrabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis D","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kontsekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Malawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-4230","authenticated-orcid":false,"given":"Luc","family":"Buee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Zilka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.ajpath.2013.11.021","volume":"184","author":"S Abbondante","year":"2014","unstructured":"Abbondante S, Baglietto-Vargas D, Rodriguez-Ortiz CJ, Estrada-Hernandez T, Medeiros R, Laferla FM (2014) Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes. Am J Pathol 184:819\u2013826. https:\/\/doi.org\/10.1016\/j.ajpath.2013.11.021","journal-title":"Am J Pathol"},{"key":"664_CR2","doi-asserted-by":"publisher","unstructured":"Adams JN, Lockhart SN, Li L, Jagust WJ (2018) Relationships between tau and glucose metabolism reflect Alzheimer\u2019s disease pathology in cognitively Normal older adults. Cereb Cortex. https:\/\/doi.org\/10.1093\/cercor\/bhy078","DOI":"10.1093\/cercor\/bhy078"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jalz.2015.06.1884","volume":"11","author":"MG Agadjanyan","year":"2015","unstructured":"Agadjanyan MG, Petrovsky N, Ghochikyan A (2015) A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease. Alzheimers Dement 11:1246\u20131259. https:\/\/doi.org\/10.1016\/j.jalz.2015.06.1884","journal-title":"Alzheimers Dement"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-017-0172-1","volume":"12","author":"MG Agadjanyan","year":"2017","unstructured":"Agadjanyan MG, Zagorski K, Petrushina I, Davtyan H, Kazarian K, Antonenko M, Davis J, Bon C, Blurton-Jones M, Cribbs DH, Ghochikyan A (2017) Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency. Mol Neurodegener 12:33. https:\/\/doi.org\/10.1186\/s13024-017-0172-1","journal-title":"Mol Neurodegener"},{"key":"664_CR5","doi-asserted-by":"publisher","unstructured":"Ahmed T, Blum D, Burnouf S, Demeyer D, Buee-Scherrer V, D'Hooge R, Buee L, Balschun D (2015) Rescue of impaired late-phase long-term depression in a tau transgenic mouse model. Neurobiol Aging 36:730\u2013739. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.09.015","DOI":"10.1016\/j.neurobiolaging.2014.09.015"},{"key":"664_CR6","doi-asserted-by":"publisher","unstructured":"Ahmed T, Van der Jeugd A, Blum D, Galas MC, D'Hooge R, Buee L, Balschun D (2014) Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion. Neurobiol Aging 35(11):2474-2478. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.05.005 .","DOI":"10.1016\/j.neurobiolaging.2014.05.005"},{"key":"664_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-013-1171-0","volume":"126","author":"Z Ahmed","year":"2013","unstructured":"Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B, Giaccone G, Hatanpaa KJ, Holton JL, Josephs KA, Powers J, Spina S, Takahashi H, White CL 3rd, Revesz T, Kovacs GG (2013) Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol 126:537\u2013544. https:\/\/doi.org\/10.1007\/s00401-013-1171-0","journal-title":"Acta Neuropathol"},{"key":"664_CR8","doi-asserted-by":"crossref","unstructured":"Albert M, Mairet-Coello G, Danis C, Lieger S, Caillierez R, Carrier S, Skrobala E, Landrieu I, Michel A, Schmitt M, Citron M, Downey P, Courade JP, Bu\u00e9e L, Colin M (2018) Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody. AAIC2018, Chicago, IL, USA.","DOI":"10.1093\/brain\/awz100"},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.nbd.2013.10.018","volume":"62","author":"G Amadoro","year":"2014","unstructured":"Amadoro G, Corsetti V, Florenzano F, Atlante A, Ciotti MT, Mongiardi MP, Bussani R, Nicolin V, Nori SL, Campanella M, Calissano P (2014) AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons. Neurobiol Dis 62:489\u2013507. https:\/\/doi.org\/10.1016\/j.nbd.2013.10.018","journal-title":"Neurobiol Dis"},{"key":"664_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3233\/jad-2010-100120","volume":"21","author":"G Amadoro","year":"2010","unstructured":"Amadoro G, Corsetti V, Stringaro A, Colone M, D'Aguanno S, Meli G, Ciotti M, Sancesario G, Cattaneo A, Bussani R, Mercanti D, Calissano P (2010) A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. J Alzheimers Dis 21:445\u2013470. https:\/\/doi.org\/10.3233\/jad-2010-100120","journal-title":"J Alzheimers Dis"},{"key":"664_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","volume":"47","author":"JC Amatniek","year":"2006","unstructured":"Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, Albert M, Brandt J, Stern Y (2006) Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47:867\u2013872. https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00554.x","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"664_CR12","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.3233\/jad-132237","volume":"40","author":"K Ando","year":"2014","unstructured":"Ando K, Kabova A, Stygelbout V, Leroy K, Heraud C, Frederick C, Suain V, Yilmaz Z, Authelet M, Dedecker R, Potier MC, Duyckaerts C, Brion JP (2014) Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study. J Alzheimers Dis 40(Suppl 1):S135\u2013S145. https:\/\/doi.org\/10.3233\/jad-132237","journal-title":"J Alzheimers Dis"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/wnl.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ (2018) Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology 91:e859\u2013e866. https:\/\/doi.org\/10.1212\/wnl.0000000000006075","journal-title":"Neurology"},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1523\/jneurosci.2361-07.2007","volume":"27","author":"AA Asuni","year":"2007","unstructured":"Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115\u20139129. https:\/\/doi.org\/10.1523\/jneurosci.2361-07.2007","journal-title":"J Neurosci"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","volume":"103","author":"JC Augustinack","year":"2002","unstructured":"Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103:26\u201335","journal-title":"Acta Neuropathol"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1586\/ern.10.40","volume":"10","author":"J Avila","year":"2010","unstructured":"Avila J, Wandosell F, Hernandez F (2010) Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert Rev Neurother 10:703\u2013710. https:\/\/doi.org\/10.1586\/ern.10.40","journal-title":"Expert Rev Neurother"},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/jpet.114.219352","volume":"352","author":"TC Baddeley","year":"2015","unstructured":"Baddeley TC, McCaffrey J, Storey JM, Cheung JK, Melis V, Horsley D, Harrington CR, Wischik CM (2015) Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease. J Pharmacol Exp Ther 352:110\u2013118. https:\/\/doi.org\/10.1124\/jpet.114.219352","journal-title":"J Pharmacol Exp Ther"},{"key":"664_CR18","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.2174\/092986711797535245","volume":"18","author":"M Bajda","year":"2011","unstructured":"Bajda M, Guzior N, Ignasik M, Malawska B (2011) Multi-target-directed ligands in Alzheimer's disease treatment. Curr Med Chem 18:4949\u20134975","journal-title":"Curr Med Chem"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","volume":"8","author":"M Baker","year":"1999","unstructured":"Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8:711\u2013715","journal-title":"Hum Mol Genet"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","volume":"15","author":"SL Baker","year":"2017","unstructured":"Baker SL, Maass A, Jagust WJ (2017) Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data Brief 15:648\u2013657. https:\/\/doi.org\/10.1016\/j.dib.2017.10.024","journal-title":"Data Brief"},{"key":"664_CR21","volume-title":"Sulfate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo [d]imidazol-2 amine, preparation thereof and use of the same","author":"MBL Barrier","year":"2014","unstructured":"Barrier MBL, Burlet S, Delacourte A, Estrella C, Melnyk P, Sergeant N, Verwaerde P (2014) Sulfate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo [d]imidazol-2 amine, preparation thereof and use of the same"},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1074-7613(00)80580-4","volume":"8","author":"FD Batista","year":"1998","unstructured":"Batista FD, Neuberger MS (1998) Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity 8:751\u2013759","journal-title":"Immunity"},{"key":"664_CR23","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD (2017) Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain 140:3286\u20133300. https:\/\/doi.org\/10.1093\/brain\/awx243","journal-title":"Brain"},{"key":"664_CR24","doi-asserted-by":"publisher","unstructured":"Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, Stone CK, Rowley HA, Johnson SC, Christian BT (2018) In vivo characterization and quantification of neurofibrillary tau PET radioligand [(18)F]MK-6240 in humans from Alzheimer's disease dementia to young controls. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.118.209650","DOI":"10.2967\/jnumed.118.209650"},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"e26860","DOI":"10.1371\/journal.pone.0026860","volume":"6","author":"M Bi","year":"2011","unstructured":"Bi M, Ittner A, Ke YD, Gotz J, Ittner LM (2011) Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice. PLoS One 6:e26860. https:\/\/doi.org\/10.1371\/journal.pone.0026860","journal-title":"PLoS One"},{"key":"664_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ymeth.2017.08.003","volume":"130","author":"GN Bischof","year":"2017","unstructured":"Bischof GN, Endepols H, van Eimeren T, Drzezga A (2017) Tau-imaging in neurodegeneration. Methods 130:114\u2013123. https:\/\/doi.org\/10.1016\/j.ymeth.2017.08.003","journal-title":"Methods"},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/acn3.339","volume":"3","author":"GN Bischof","year":"2016","unstructured":"Bischof GN, Jessen F, Fliessbach K, Dronse J, Hammes J, Neumaier B, Onur O, Fink GR, Kukolja J, Drzezga A, van Eimeren T (2016) Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease. Ann Clin Transl Neurol 3:934\u2013939. https:\/\/doi.org\/10.1002\/acn3.339","journal-title":"Ann Clin Transl Neurol"},{"key":"664_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/bf02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E (1995) Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26:231\u2013245. https:\/\/doi.org\/10.1007\/bf02815140","journal-title":"Mol Chem Neuropathol"},{"key":"664_CR29","doi-asserted-by":"publisher","unstructured":"Blennow K, Zetterberg H (2018) Biomarkers for Alzheimer's disease: current status and prospects for the future. J Intern Med. https:\/\/doi.org\/10.1111\/joim.12816","DOI":"10.1111\/joim.12816"},{"key":"664_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.expneurol.2010.05.010","volume":"224","author":"M Boimel","year":"2010","unstructured":"Boimel M, Grigoriadis N, Lourbopoulos A, Haber E, Abramsky O, Rosenmann H (2010) Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice. Exp Neurol 224:472\u2013485. https:\/\/doi.org\/10.1016\/j.expneurol.2010.05.010","journal-title":"Exp Neurol"},{"key":"664_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","volume":"129","author":"S Boluda","year":"2015","unstructured":"Boluda S, Iba M, Zhang B, Raible KM, Lee VM, Trojanowski JQ (2015) Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains. Acta Neuropathol 129:221\u2013237. https:\/\/doi.org\/10.1007\/s00401-014-1373-0","journal-title":"Acta Neuropathol"},{"key":"664_CR32","first-page":"711","volume":"137","author":"W Bondareff","year":"1990","unstructured":"Bondareff W, Wischik CM, Novak M, Amos WB, Klug A, Roth M (1990) Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. Am J Pathol 137:711\u2013723","journal-title":"Am J Pathol"},{"key":"664_CR33","doi-asserted-by":"publisher","first-page":"e84442","DOI":"10.1371\/journal.pone.0084442","volume":"8","author":"P Borghgraef","year":"2013","unstructured":"Borghgraef P, Menuet C, Theunis C, Louis JV, Devijver H, Maurin H, Smet-Nocca C, Lippens G, Hilaire G, Gijsen H, Moechars D, Van Leuven F (2013) Increasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of tau.P301L mice. PLoS One 8:e84442. https:\/\/doi.org\/10.1371\/journal.pone.0084442","journal-title":"PLoS One"},{"key":"664_CR34","doi-asserted-by":"publisher","first-page":"8124","DOI":"10.1007\/s12035-018-0974-3","volume":"55","author":"A Borreca","year":"2018","unstructured":"Borreca A, Latina V, Corsetti V, Middei S, Piccinin S, Della Valle F, Bussani R, Ammassari-Teule M, Nistico R, Calissano P, Amadoro G (2018) AD-related N-terminal truncated tau is sufficient to recapitulate in vivo the early perturbations of human neuropathology: implications for immunotherapy. Mol Neurobiol 55:8124\u20138153. https:\/\/doi.org\/10.1007\/s12035-018-0974-3","journal-title":"Mol Neurobiol"},{"key":"664_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41467-017-00633-1","volume":"8","author":"E Bou Samra","year":"2017","unstructured":"Bou Samra E, Buhagiar-Labarchede G, Machon C, Guitton J, Onclercq-Delic R, Green MR, Alibert O, Gazin C, Veaute X, Amor-Gueret M (2017) A role for tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival. Nat Commun 8:693. https:\/\/doi.org\/10.1038\/s41467-017-00633-1","journal-title":"Nat Commun"},{"key":"664_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","volume":"118","author":"A Boutajangout","year":"2011","unstructured":"Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM (2011) Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem 118:658\u2013667. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07337.x","journal-title":"J Neurochem"},{"key":"664_CR37","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.1523\/jneurosci.4363-10.2010","volume":"30","author":"A Boutajangout","year":"2010","unstructured":"Boutajangout A, Quartermain D, Sigurdsson EM (2010) Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J Neurosci 30:16559\u201316566. https:\/\/doi.org\/10.1523\/jneurosci.4363-10.2010","journal-title":"J Neurosci"},{"key":"664_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"664_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"664_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E (1995) Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16:271\u2013278 discussion 278-284","journal-title":"Neurobiol Aging"},{"key":"664_CR41","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","volume":"10","author":"GT Bramblett","year":"1993","unstructured":"Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089\u20131099","journal-title":"Neuron"},{"key":"664_CR42","doi-asserted-by":"publisher","first-page":"338ra366","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, Ances BM (2016) Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med 8:338ra366. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2362","journal-title":"Sci Transl Med"},{"key":"664_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","volume":"36","author":"J Bright","year":"2015","unstructured":"Bright J, Hussain S, Dang V, Wright S, Cooper B, Byun T, Ramos C, Singh A, Parry G, Stagliano N, Griswold-Prenner I (2015) Human secreted tau increases amyloid-beta production. Neurobiol Aging 36:693\u2013709. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.09.007","journal-title":"Neurobiol Aging"},{"key":"664_CR44","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1242\/jcs.204206","volume":"130","author":"D Brough","year":"2017","unstructured":"Brough D, Pelegrin P, Nickel W (2017) An emerging case for membrane pore formation as a common mechanism for the unconventional secretion of FGF2 and IL-1beta. J Cell Sci 130:3197\u20133202. https:\/\/doi.org\/10.1242\/jcs.204206","journal-title":"J Cell Sci"},{"key":"664_CR45","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jamaneurol.2017.2216","volume":"74","author":"RF Buckley","year":"2017","unstructured":"Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, Jackson JD, Mormino EC, Rentz DM, Sperling RA, Johnson KA, Amariglio RE (2017) Region-specific Association of Subjective Cognitive Decline with Tauopathy Independent of global beta-amyloid burden. JAMA Neurol 74:1455\u20131463. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2216","journal-title":"JAMA Neurol"},{"key":"664_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","volume":"33","author":"L Buee","year":"2000","unstructured":"Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95\u2013130","journal-title":"Brain Res Brain Res Rev"},{"key":"664_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neuropharm.2010.01.016","volume":"59","author":"B Bulic","year":"2010","unstructured":"Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E (2010) Tau protein and tau aggregation inhibitors. Neuropharmacology 59:276\u2013289. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.01.016","journal-title":"Neuropharmacology"},{"key":"664_CR48","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/anie.200802621","volume":"48","author":"B Bulic","year":"2009","unstructured":"Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E (2009) Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed Engl 48:1740\u20131752. https:\/\/doi.org\/10.1002\/anie.200802621","journal-title":"Angew Chem Int Ed Engl"},{"key":"664_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/acel.12018","volume":"12","author":"S Burnouf","year":"2013","unstructured":"Burnouf S, Martire A, Derisbourg M, Laurent C, Belarbi K, Leboucher A, Fernandez-Gomez FJ, Troquier L, Eddarkaoui S, Grosjean ME, Demeyer D, Muhr-Tailleux A, Buisson A, Sergeant N, Hamdane M, Humez S, Popoli P, Buee L, Blum D (2013) NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a tau transgenic model. Aging Cell 12:11\u201323. https:\/\/doi.org\/10.1111\/acel.12018","journal-title":"Aging Cell"},{"key":"664_CR50","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.neurobiolaging.2007.05.002","volume":"29","author":"TM Caffrey","year":"2008","unstructured":"Caffrey TM, Joachim C, Wade-Martins R (2008) Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus. Neurobiol Aging 29:1923\u20131929. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.05.002","journal-title":"Neurobiol Aging"},{"key":"664_CR51","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2174\/156720512802455386","volume":"9","author":"Z Cai","year":"2012","unstructured":"Cai Z, Zhao Y, Zhao B (2012) Roles of glycogen synthase kinase 3 in Alzheimer's disease. Curr Alzheimer Res 9:864\u2013879","journal-title":"Curr Alzheimer Res"},{"key":"664_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.celrep.2016.09.063","volume":"17","author":"S Calafate","year":"2016","unstructured":"Calafate S, Flavin W, Verstreken P, Moechars D (2016) Loss of Bin1 promotes the propagation of tau pathology. Cell Rep 17:931\u2013940. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.063","journal-title":"Cell Rep"},{"key":"664_CR53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3233\/jad-131415","volume":"39","author":"S Camero","year":"2014","unstructured":"Camero S, Benitez MJ, Barrantes A, Ayuso JM, Cuadros R, Avila J, Jimenez JS (2014) Tau protein provides DNA with thermodynamic and structural features which are similar to those found in histone-DNA complex. J Alzheimers Dis 39:649\u2013660. https:\/\/doi.org\/10.3233\/jad-131415","journal-title":"J Alzheimers Dis"},{"key":"664_CR54","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1523\/jneurosci.3192-13.2014","volume":"34","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Lasagna-Reeves CA, Gerson JE, Singh G, Estes DM, Barrett AD, Dineley KT, Jackson GR, Kayed R (2014) Passive immunization with tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci 34:4260\u20134272. https:\/\/doi.org\/10.1523\/jneurosci.3192-13.2014","journal-title":"J Neurosci"},{"key":"664_CR55","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nbd.2012.05.021","volume":"48","author":"X Chai","year":"2012","unstructured":"Chai X, Dage JL, Citron M (2012) Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol Dis 48:356\u2013366. https:\/\/doi.org\/10.1016\/j.nbd.2012.05.021","journal-title":"Neurobiol Dis"},{"key":"664_CR56","doi-asserted-by":"publisher","unstructured":"Chai X, Wu S, Murray TK, Kinley R, Cella CV, Sims H, Buckner N, Hanmer J, Davies P, O'Neill MJ, Hutton ML, Citron M (2011) Passive immunization with anti-tau antibodies in two transgenic models: reduction of tau pathology and delay of disease progression. J Biol Chem 286:34457\u201334467. https:\/\/doi.org\/10.1074\/jbc.M111.229633","DOI":"10.1074\/jbc.M111.229633"},{"key":"664_CR57","doi-asserted-by":"publisher","first-page":"e115765","DOI":"10.1371\/journal.pone.0115765","volume":"9","author":"JS Cheng","year":"2014","unstructured":"Cheng JS, Craft R, Yu GQ, Ho K, Wang X, Mohan G, Mangnitsky S, Ponnusamy R, Mucke L (2014) Tau reduction diminishes spatial learning and memory deficits after mild repetitive traumatic brain injury in mice. PLoS One 9:e115765. https:\/\/doi.org\/10.1371\/journal.pone.0115765","journal-title":"PLoS One"},{"key":"664_CR58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, Lee JH, Ryu YH, Lee MS, Lyoo CH (2016) In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol 80:247\u2013258. https:\/\/doi.org\/10.1002\/ana.24711","journal-title":"Ann Neurol"},{"key":"664_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2967\/jnumed.117.195248","volume":"59","author":"JY Choi","year":"2018","unstructured":"Choi JY, Cho H, Ahn SJ, Lee JH, Ryu YH, Lee MS, Lyoo CH (2018) Off-target (18)F-AV-1451 binding in the basal ganglia correlates with age-related Iron accumulation. J Nucl Med 59:117\u2013120. https:\/\/doi.org\/10.2967\/jnumed.117.195248","journal-title":"J Nucl Med"},{"key":"664_CR60","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, Probst A, Winkler DT, Reichwald J, Staufenbiel M, Ghetti B, Goedert M, Tolnay M (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A 110:9535\u20139540. https:\/\/doi.org\/10.1073\/pnas.1301175110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR61","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awu213","volume":"137","author":"L Collin","year":"2014","unstructured":"Collin L, Bohrmann B, Gopfert U, Oroszlan-Szovik K, Ozmen L, Gruninger F (2014) Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease. Brain 137:2834\u20132846. https:\/\/doi.org\/10.1093\/brain\/awu213","journal-title":"Brain"},{"key":"664_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nbd.2016.05.016","volume":"94","author":"B Combs","year":"2016","unstructured":"Combs B, Hamel C, Kanaan NM (2016) Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies. Neurobiol Dis 94:18\u201331. https:\/\/doi.org\/10.1016\/j.nbd.2016.05.016","journal-title":"Neurobiol Dis"},{"key":"664_CR63","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ajpath.2017.01.019","volume":"187","author":"B Combs","year":"2017","unstructured":"Combs B, Kanaan NM (2017) Exposure of the amino terminus of tau is a pathological event in multiple Tauopathies. Am J Pathol 187:1222\u20131229. https:\/\/doi.org\/10.1016\/j.ajpath.2017.01.019","journal-title":"Am J Pathol"},{"key":"664_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-016-0126-z","volume":"11","author":"EE Congdon","year":"2016","unstructured":"Congdon EE, Lin Y, Rajamohamedsait HB, Shamir DB, Krishnaswamy S, Rajamohamedsait WJ, Rasool S, Gonzalez V, Levenga J, Gu J, Hoeffer C, Sigurdsson EM (2016) Affinity of tau antibodies for solubilized pathological tau species but not their immunogen or insoluble tau aggregates predicts in vivo and ex vivo efficacy. Mol Neurodegener 11:62. https:\/\/doi.org\/10.1186\/s13024-016-0126-z","journal-title":"Mol Neurodegener"},{"key":"664_CR65","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 14:399\u2013415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nat Rev Neurol"},{"key":"664_CR66","doi-asserted-by":"crossref","unstructured":"Cooper H M and Paterson Y. Determination of specific antibody titer. Current protocols in Molecular Biology. 2000, 11.17.1-11.17.13, John Wiley & Sons, Inc.","DOI":"10.1002\/0471142727.mb1117s50"},{"key":"664_CR67","doi-asserted-by":"publisher","unstructured":"Courade J-P, Angers R, Mairet-Coello G, Pacico N, Tyson K, Lightwood D, Munro R, McMillan D, Griffin R, Baker T, Starkie D, Nan R, Westwood M, Mushikiwabo M-L, Jung S, Odede G, Sweeney B, Popplewell A, Burgess G, Downey P, Citron MJAN (2018) Epitope determines efficacy of therapeutic anti-tau antibodies in a functional assay with human Alzheimer tau. 136:729\u2013745. https:\/\/doi.org\/10.1007\/s00401-018-1911-2","DOI":"10.1007\/s00401-018-1911-2"},{"key":"664_CR68","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766. https:\/\/doi.org\/10.1007\/s00401-014-1349-0","journal-title":"Acta Neuropathol"},{"key":"664_CR69","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/nat.2016.0656","volume":"27","author":"ST Crooke","year":"2017","unstructured":"Crooke ST (2017) Molecular mechanisms of antisense oligonucleotides. Nucleic Acid Ther 27:70\u201377. https:\/\/doi.org\/10.1089\/nat.2016.0656","journal-title":"Nucleic Acid Ther"},{"key":"664_CR70","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.1021\/bi9006435","volume":"48","author":"A Crowe","year":"2009","unstructured":"Crowe A, Huang W, Ballatore C, Johnson RL, Hogan AM, Huang R, Wichterman J, McCoy J, Huryn D, Auld DS, Smith AB 3rd, Inglese J, Trojanowski JQ, Austin CP, Brunden KR, Lee VM (2009) Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. Biochemistry 48:7732\u20137745. https:\/\/doi.org\/10.1021\/bi9006435","journal-title":"Biochemistry"},{"key":"664_CR71","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.trci.2018.03.009","volume":"4","author":"J Cummings","year":"2018","unstructured":"Cummings J, Lee G, Ritter A, Zhong K (2018) Alzheimer's disease drug development pipeline: 2018. Alzheimers Dement (N Y) 4:195\u2013214. https:\/\/doi.org\/10.1016\/j.trci.2018.03.009","journal-title":"Alzheimers Dement (N Y)"},{"key":"664_CR72","doi-asserted-by":"publisher","first-page":"e62402","DOI":"10.1371\/journal.pone.0062402","volume":"8","author":"C d'Abramo","year":"2013","unstructured":"d'Abramo C, Acker CM, Jimenez HT, Davies P (2013) Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. PLoS One 8:e62402. https:\/\/doi.org\/10.1371\/journal.pone.0062402","journal-title":"PLoS One"},{"key":"664_CR73","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","volume":"122","author":"CL Dai","year":"2015","unstructured":"Dai CL, Chen X, Kazim SF, Liu F, Gong CX, Grundke-Iqbal I, Iqbal K (2015) Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies. J Neural Transm (Vienna) 122:607\u2013617. https:\/\/doi.org\/10.1007\/s00702-014-1315-y","journal-title":"J Neural Transm (Vienna)"},{"key":"664_CR74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2018.01.024","volume":"66","author":"SR Das","year":"2018","unstructured":"Das SR, Xie L, Wisse LEM, Ittyerah R, Tustison NJ, Dickerson BC, Yushkevich PA, Wolk DA (2018) Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake. Neurobiol Aging 66:49\u201358. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.01.024","journal-title":"Neurobiol Aging"},{"key":"664_CR75","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A Calignon de","year":"2012","unstructured":"de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73:685\u2013697. https:\/\/doi.org\/10.1016\/j.neuron.2011.11.033","journal-title":"Neuron"},{"key":"664_CR76","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/jad-2012-120805","volume":"33","author":"T Ser del","year":"2013","unstructured":"del Ser T, Steinwachs KC, Gertz HJ, Andres MV, Gomez-Carrillo B, Medina M, Vericat JA, Redondo P, Fleet D, Leon T (2013) Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study. J Alzheimers Dis 33:205\u2013215. https:\/\/doi.org\/10.3233\/jad-2012-120805","journal-title":"J Alzheimers Dis"},{"key":"664_CR77","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0197-4580(93)90096-T","volume":"14","author":"P Delaere","year":"1993","unstructured":"Delaere P, He Y, Fayet G, Duyckaerts C, Hauw JJ (1993) Beta A4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiol Aging 14:191\u2013194","journal-title":"Neurobiol Aging"},{"key":"664_CR78","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.1038\/srep09659","volume":"5","author":"M Derisbourg","year":"2015","unstructured":"Derisbourg M, Leghay C, Chiappetta G, Fernandez-Gomez FJ, Laurent C, Demeyer D, Carrier S, Buee-Scherrer V, Blum D, Vinh J, Sergeant N, Verdier Y, Buee L, Hamdane M (2015) Role of the tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms. Sci Rep 5:9659. https:\/\/doi.org\/10.1038\/srep09659","journal-title":"Sci Rep"},{"key":"664_CR79","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1523\/jneurosci.1487-05.2005","volume":"25","author":"P Derkinderen","year":"2005","unstructured":"Derkinderen P, Scales TM, Hanger DP, Leung KY, Byers HL, Ward MA, Lenz C, Price C, Bird IN, Perera T, Kellie S, Williamson R, Noble W, Van Etten RA, Leroy K, Brion JP, Reynolds CH, Anderton BH (2005) Tyrosine 394 is phosphorylated in Alzheimer\u2019s paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J Neurosci 25:6584\u20136593. https:\/\/doi.org\/10.1523\/jneurosci.1487-05.2005","journal-title":"J Neurosci"},{"key":"664_CR80","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/brain\/awy117","volume":"141","author":"SL DeVos","year":"2018","unstructured":"DeVos SL, Corjuc BT, Commins C, Dujardin S, Bannon RN, Corjuc D, Moore BD, Bennett RE, Jorfi M, Gonzales JA, Dooley PM, Roe AD, Pitstick R, Irimia D, Frosch MP, Carlson GA, Hyman BT (2018) Tau reduction in the presence of amyloid-beta prevents tau pathology and neuronal death in vivo. Brain 141:2194\u20132212. https:\/\/doi.org\/10.1093\/brain\/awy117","journal-title":"Brain"},{"key":"664_CR81","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/jneurosci.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Goncharoff DK, Chen G, Kebodeaux CS, Yamada K, Stewart FR, Schuler DR, Maloney SE, Wozniak DF, Rigo F, Bennett CF, Cirrito JR, Holtzman DM, Miller TM (2013) Antisense reduction of tau in adult mice protects against seizures. J Neurosci 33:12887\u201312897. https:\/\/doi.org\/10.1523\/jneurosci.2107-13.2013","journal-title":"J Neurosci"},{"key":"664_CR82","doi-asserted-by":"publisher","unstructured":"DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ, Chen G, Shen T, Tran H, Nichols B, Zanardi TA, Kordasiewicz HB, Swayze EE, Bennett CF, Diamond MI, Miller TM (2017) Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci Transl Med 9. https:\/\/doi.org\/10.1126\/scitranslmed.aag0481","DOI":"10.1126\/scitranslmed.aag0481"},{"key":"664_CR83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1570159x1203140511153200","volume":"12","author":"KS Dias","year":"2014","unstructured":"Dias KS, Viegas C Jr (2014) Multi-target directed drugs: a modern approach for Design of new Drugs for the treatment of Alzheimer's disease. Curr Neuropharmacol 12:239\u2013255. https:\/\/doi.org\/10.2174\/1570159x1203140511153200","journal-title":"Curr Neuropharmacol"},{"key":"664_CR84","doi-asserted-by":"publisher","unstructured":"D\u00edaz-Hern\u00e1ndez M, Gomez-Ramos A, Rubio A, Gomez-Villafuertes R, Naranjo JR, Miras-Portugal MT, Avila J (2010) Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J Biol Chem 285:32539\u201332548. https:\/\/doi.org\/10.1074\/jbc.M110.145003","DOI":"10.1074\/jbc.M110.145003"},{"key":"664_CR85","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"DW Dickson","year":"2002","unstructured":"Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935\u2013946","journal-title":"J Neuropathol Exp Neurol"},{"key":"664_CR86","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2017.6669","volume":"317","author":"MC Donohue","year":"2017","unstructured":"Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS (2017) Association between elevated brain amyloid and subsequent cognitive decline among cognitively Normal persons. Jama 317:2305\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.6669","journal-title":"Jama"},{"key":"664_CR87","doi-asserted-by":"publisher","unstructured":"Dorval V, Fraser PE (2006) Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem 281:9919\u20139924. https:\/\/doi.org\/10.1074\/jbc.M510127200","DOI":"10.1074\/jbc.M510127200"},{"key":"664_CR88","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s1474-4422(18)30029-2","volume":"17","author":"B Dubois","year":"2018","unstructured":"Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O, Houot M, Lista S, Cacciamani F, Potier MC, Bertrand A, Lamari F, Benali H, Mangin JF, Colliot O, Genthon R, Habert MO, Hampel H (2018) Cognitive and neuroimaging features and brain beta-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol 17:335\u2013346. https:\/\/doi.org\/10.1016\/s1474-4422(18)30029-2","journal-title":"Lancet Neurol"},{"key":"664_CR89","doi-asserted-by":"publisher","first-page":"e100760","DOI":"10.1371\/journal.pone.0100760","volume":"9","author":"S Dujardin","year":"2014","unstructured":"Dujardin S, Begard S, Caillierez R, Lachaud C, Delattre L, Carrier S, Loyens A, Galas MC, Bousset L, Melki R, Auregan G, Hantraye P, Brouillet E, Buee L, Colin M (2014) Ectosomes: a new mechanism for non-exosomal secretion of tau protein. PLoS One 9:e100760. https:\/\/doi.org\/10.1371\/journal.pone.0100760","journal-title":"PLoS One"},{"key":"664_CR90","doi-asserted-by":"crossref","unstructured":"Dujardin S, Lachaud C, Caillierez R, B\u00e9gard S, Carrier S, Lieger S, Gonzales JA, Moore BD, Deramecourt V, Deglon N, Maurage CA, Frosch MP, Hyman BT, Colin M, Bu\u00e9e L (2018) Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun 6:132.","DOI":"10.1186\/s40478-018-0637-7"},{"key":"664_CR91","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/S0197-4580(97)00067-5","volume":"18","author":"C Duyckaerts","year":"1997","unstructured":"Duyckaerts C, Hauw JJ (1997) Diagnosis and staging of Alzheimer disease. Neurobiol Aging 18:S33\u2013S42","journal-title":"Neurobiol Aging"},{"key":"664_CR92","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0197-4580(97)00047-X","volume":"18","author":"C Duyckaerts","year":"1997","unstructured":"Duyckaerts C, Hauw JJ (1997) Prevalence, incidence and duration of Braak's stages in the general population: can we know? Neurobiol Aging 18:362\u2013369 discussion 389-392","journal-title":"Neurobiol Aging"},{"key":"664_CR93","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","volume":"99","author":"B Eftekharzadeh","year":"2018","unstructured":"Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ, Dujardin S, Amaral AS, Grima JC, Bennett RE, Tepper K, DeTure M, Vanderburgh CR, Corjuc BT, DeVos SL, Gonzalez JA, Chew J, Vidensky S, Gage FH, Mertens J, Troncoso J, Mandelkow E, Salvatella X, Lim RYH, Petrucelli L, Wegmann S, Rothstein JD, Hyman BT (2018) Tau protein disrupts nucleocytoplasmic transport in Alzheimer's disease. Neuron 99:925\u2013940.e927. https:\/\/doi.org\/10.1016\/j.neuron.2018.07.039","journal-title":"Neuron"},{"key":"664_CR94","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","volume":"13","author":"FM Elahi","year":"2017","unstructured":"Elahi FM, Miller BL (2017) A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 13:457\u2013476. https:\/\/doi.org\/10.1038\/nrneurol.2017.96","journal-title":"Nat Rev Neurol"},{"key":"664_CR95","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1016\/j.celrep.2018.03.021","volume":"22","author":"LD Evans","year":"2018","unstructured":"Evans LD, Wassmer T, Fraser G, Smith J, Perkinton M, Billinton A, Livesey FJ (2018) Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways. Cell Rep 22:3612\u20133624. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.021","journal-title":"Cell Rep"},{"key":"664_CR96","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","volume":"87","author":"MM Evers","year":"2015","unstructured":"Evers MM, Toonen LJ, van Roon-Mom WM (2015) Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv Drug Deliv Rev 87:90\u2013103. https:\/\/doi.org\/10.1016\/j.addr.2015.03.008","journal-title":"Adv Drug Deliv Rev"},{"key":"664_CR97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/nen.0000000000000030","volume":"73","author":"I Ferrer","year":"2014","unstructured":"Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R, Kovacs GG (2014) Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 73:81\u201397. https:\/\/doi.org\/10.1097\/nen.0000000000000030","journal-title":"J Neuropathol Exp Neurol"},{"key":"664_CR98","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.neurobiolaging.2010.10.015","volume":"33","author":"P Filipcik","year":"2012","unstructured":"Filipcik P, Zilka N, Bugos O, Kucerak J, Koson P, Novak P, Novak M (2012) First transgenic rat model developing progressive cortical neurofibrillary tangles. Neurobiol Aging 33:1448\u20131456. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.10.015","journal-title":"Neurobiol Aging"},{"key":"664_CR99","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, Crowther RA, Ghetti B, Goedert M, Scheres SHW (2017) Cryo-EM structures of tau filaments from Alzheimer's disease. Nature 547:185\u2013190. https:\/\/doi.org\/10.1038\/nature23002","journal-title":"Nature"},{"key":"664_CR100","doi-asserted-by":"publisher","first-page":"64745","DOI":"10.18632\/oncotarget.17371","volume":"8","author":"F Florenzano","year":"2017","unstructured":"Florenzano F, Veronica C, Ciasca G, Ciotti MT, Pittaluga A, Olivero G, Feligioni M, Iannuzzi F, Latina V, Maria Sciacca MF, Sinopoli A, Milardi D, Pappalardo G, Marco S, Papi M, Atlante A, Bobba A, Borreca A, Calissano P, Amadoro G (2017) Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer's disease and other tauopathies. Oncotarget 8:64745\u201364778. https:\/\/doi.org\/10.18632\/oncotarget.17371","journal-title":"Oncotarget"},{"key":"664_CR101","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awx328","volume":"141","author":"SL Forrest","year":"2018","unstructured":"Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC, Gotz J, Spillantini MG, Hodges JR, Ittner LM, Halliday GM (2018) Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141:521\u2013534. https:\/\/doi.org\/10.1093\/brain\/awx328","journal-title":"Brain"},{"key":"664_CR102","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1523\/jneurosci.4261-13.2014","volume":"34","author":"ML Frandemiche","year":"2014","unstructured":"Frandemiche ML, De Seranno S, Rush T, Borel E, Elie A, Arnal I, Lante F, Buisson A (2014) Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. J Neurosci 34:6084\u20136097. https:\/\/doi.org\/10.1523\/jneurosci.4261-13.2014","journal-title":"J Neurosci"},{"key":"664_CR103","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cub.2015.11.039","volume":"26","author":"B Frost","year":"2016","unstructured":"Frost B, Bardai FH, Feany MB (2016) Lamin dysfunction mediates neurodegeneration in Tauopathies. Curr Biol 26:129\u2013136. https:\/\/doi.org\/10.1016\/j.cub.2015.11.039","journal-title":"Curr Biol"},{"key":"664_CR104","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nn.3639","volume":"17","author":"B Frost","year":"2014","unstructured":"Frost B, Hemberg M, Lewis J, Feany MB (2014) Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci 17:357\u2013366. https:\/\/doi.org\/10.1038\/nn.3639","journal-title":"Nat Neurosci"},{"key":"664_CR105","doi-asserted-by":"publisher","unstructured":"Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845\u201312852. https:\/\/doi.org\/10.1074\/jbc.M808759200","DOI":"10.1074\/jbc.M808759200"},{"key":"664_CR106","doi-asserted-by":"publisher","first-page":"e0159463","DOI":"10.1371\/journal.pone.0159463","volume":"11","author":"H Fu","year":"2016","unstructured":"Fu H, Hussaini SA, Wegmann S, Profaci C, Daniels JD, Herman M, Emrani S, Figueroa HY, Hyman BT, Davies P, Duff KE (2016) 3D visualization of the temporal and spatial spread of tau pathology reveals extensive sites of tau accumulation associated with neuronal loss and recognition memory deficit in aged tau transgenic mice. PLoS One 11:e0159463. https:\/\/doi.org\/10.1371\/journal.pone.0159463","journal-title":"PLoS One"},{"key":"664_CR107","doi-asserted-by":"publisher","unstructured":"Funk KE, Mirbaha H, Jiang H, Holtzman DM, Diamond MI (2015) Distinct therapeutic mechanisms of tau antibodies: promoting microglial clearance versus blocking neuronal uptake. J Biol Chem 290:21652\u201321662. https:\/\/doi.org\/10.1074\/jbc.M115.657924","DOI":"10.1074\/jbc.M115.657924"},{"key":"664_CR108","doi-asserted-by":"publisher","unstructured":"Fuster-Matanzo A, Hernandez F, Avila J (2018) Tau spreading mechanisms; implications for dysfunctional Tauopathies. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19030645","DOI":"10.3390\/ijms19030645"},{"key":"664_CR109","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1021\/acs.jmedchem.8b00610","volume":"61","author":"A Gandini","year":"2018","unstructured":"Gandini A, Bartolini M, Tedesco D, Martinez-Gonzalez L, Roca C, Campillo NE, Zaldivar-Diez J, Perez C, Zuccheri G, Miti A, Feoli A, Castellano S, Petralla S, Monti B, Rossi M, Moda F, Legname G, Martinez A, Bolognesi ML (2018) Tau-centric multitarget approach for Alzheimer's disease: development of first-in-class dual glycogen synthase kinase 3beta and tau-aggregation inhibitors. J Med Chem 61:7640\u20137656. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00610","journal-title":"J Med Chem"},{"key":"664_CR110","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/s0140-6736(16)31275-2","volume":"388","author":"S Gauthier","year":"2016","unstructured":"Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ, Schelter BO, Davis CS, Staff RT, Bracoud L, Shamsi K, Storey JM, Harrington CR, Wischik CM (2016) Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet 388:2873\u20132884. https:\/\/doi.org\/10.1016\/s0140-6736(16)31275-2","journal-title":"Lancet"},{"key":"664_CR111","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nan.12213","volume":"41","author":"B Ghetti","year":"2015","unstructured":"Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M (2015) Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 41:24\u201346. https:\/\/doi.org\/10.1111\/nan.12213","journal-title":"Neuropathol Appl Neurobiol"},{"key":"664_CR112","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ana.24230","volume":"76","author":"AL Gheyara","year":"2014","unstructured":"Gheyara AL, Ponnusamy R, Djukic B, Craft RJ, Ho K, Guo W, Finucane MM, Sanchez PE, Mucke L (2014) Tau reduction prevents disease in a mouse model of Dravet syndrome. Ann Neurol 76:443\u2013456. https:\/\/doi.org\/10.1002\/ana.24230","journal-title":"Ann Neurol"},{"key":"664_CR113","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/archneur.55.5.689","volume":"55","author":"P Giannakopoulos","year":"1998","unstructured":"Giannakopoulos P, Duc M, Gold G, Hof PR, Michel JP, Bouras C (1998) Pathologic correlates of apraxia in Alzheimer disease. Arch Neurol 55:689\u2013695","journal-title":"Arch Neurol"},{"key":"664_CR114","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1212\/WNL.52.1.71","volume":"52","author":"P Giannakopoulos","year":"1999","unstructured":"Giannakopoulos P, Gold G, Duc M, Michel JP, Hof PR, Bouras C (1999) Neuroanatomic correlates of visual agnosia in Alzheimer's disease: a clinicopathologic study. Neurology 52:71\u201377","journal-title":"Neurology"},{"key":"664_CR115","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s004019900166","volume":"100","author":"P Giannakopoulos","year":"2000","unstructured":"Giannakopoulos P, Gold G, Duc M, Michel JP, Hof PR, Bouras C (2000) Neural substrates of spatial and temporal disorientation in Alzheimer's disease. Acta Neuropathol 100:189\u2013195","journal-title":"Acta Neuropathol"},{"key":"664_CR116","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, Morrison JH, Gold G, Hof PR (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60:1495\u20131500","journal-title":"Neurology"},{"key":"664_CR117","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","volume":"9","author":"M Goedert","year":"1990","unstructured":"Goedert M, Jakes R (1990) Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 9:4225\u20134230","journal-title":"EMBO J"},{"key":"664_CR118","doi-asserted-by":"crossref","unstructured":"Goedert M, Spillantini MG (2001) Tau gene mutations and neurodegeneration. Biochem Soc Symp 67:59\u201371","DOI":"10.1042\/bss0670059"},{"key":"664_CR119","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/j.1460-2075.1989.tb03390.x","volume":"8","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8:393\u2013399","journal-title":"EMBO J"},{"key":"664_CR120","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","volume":"85","author":"M Goedert","year":"1988","unstructured":"Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A 85:4051\u20134055","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR121","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s004010051163","volume":"99","author":"G Gold","year":"2000","unstructured":"Gold G, Bouras C, Kovari E, Canuto A, Glaria BG, Malky A, Hof PR, Michel JP, Giannakopoulos P (2000) Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol 99:579\u2013582 discussion 583-574","journal-title":"Acta Neuropathol"},{"key":"664_CR122","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1016\/j.febslet.2006.07.078","volume":"580","author":"A Gomez-Ramos","year":"2006","unstructured":"Gomez-Ramos A, Diaz-Hernandez M, Cuadros R, Hernandez F, Avila J (2006) Extracellular tau is toxic to neuronal cells. FEBS Lett 580:4842\u20134850. https:\/\/doi.org\/10.1016\/j.febslet.2006.07.078","journal-title":"FEBS Lett"},{"key":"664_CR123","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.mcn.2007.12.010","volume":"37","author":"A Gomez-Ramos","year":"2008","unstructured":"Gomez-Ramos A, Diaz-Hernandez M, Rubio A, Miras-Portugal MT, Avila J (2008) Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells. Mol Cell Neurosci 37:673\u2013681. https:\/\/doi.org\/10.1016\/j.mcn.2007.12.010","journal-title":"Mol Cell Neurosci"},{"key":"664_CR124","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/brain\/aww139","volume":"139","author":"BA Gordon","year":"2016","unstructured":"Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances BM, Benzinger TL (2016) The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain 139:2249\u20132260. https:\/\/doi.org\/10.1093\/brain\/aww139","journal-title":"Brain"},{"key":"664_CR125","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.dadm.2018.02.003","volume":"10","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, McCullough A, Mishra S, Blazey TM, Su Y, Christensen J, Dincer A, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TLS (2018) Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid beta positron emission tomography pathology. Alzheimers Dement (Amst) 10:245\u2013252. https:\/\/doi.org\/10.1016\/j.dadm.2018.02.003","journal-title":"Alzheimers Dement (Amst)"},{"key":"664_CR126","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0197-4580(99)00063-9","volume":"20","author":"E Grober","year":"1999","unstructured":"Grober E, Dickson D, Sliwinski MJ, Buschke H, Katz M, Crystal H, Lipton RB (1999) Memory and mental status correlates of modified Braak staging. Neurobiol Aging 20:573\u2013579","journal-title":"Neurobiol Aging"},{"key":"664_CR127","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913\u20134917","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR128","doi-asserted-by":"publisher","unstructured":"Gu H, Dodel R, Farlow M, Du Y (2014) Advances in the development of antibody-based immunotherapy against prion disease. https:\/\/doi.org\/10.2147\/ANTI.S53336","DOI":"10.2147\/ANTI.S53336"},{"key":"664_CR129","doi-asserted-by":"publisher","unstructured":"Gu J, Congdon EE, Sigurdsson EM (2013) Two novel tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce tau protein pathology. J Biol Chem 288:33081\u201333095. https:\/\/doi.org\/10.1074\/jbc.M113.494922","DOI":"10.1074\/jbc.M113.494922"},{"key":"664_CR130","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1242\/jcs.01724","volume":"118","author":"M Hamdane","year":"2005","unstructured":"Hamdane M, Bretteville A, Sambo AV, Schindowski K, Begard S, Delacourte A, Bertrand P, Buee L (2005) p25\/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci 118:1291\u20131298. https:\/\/doi.org\/10.1242\/jcs.01724","journal-title":"J Cell Sci"},{"key":"664_CR131","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jalz.2017.11.015","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel H, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Melo Dos Santos A, Epelbaum S, Lamari F, Genthon R, Dubois B, Floris R, Garaci F, Lista S (2018) Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Abeta1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40. Alzheimers Dement 14:492\u2013501. https:\/\/doi.org\/10.1016\/j.jalz.2017.11.015","journal-title":"Alzheimers Dement"},{"key":"664_CR132","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ana.24910","volume":"81","author":"BJ Hanseeuw","year":"2017","unstructured":"Hanseeuw BJ, Betensky RA, Schultz AP, Papp KV, Mormino EC, Sepulcre J, Bark JS, Cosio DM, LaPoint M, Chhatwal JP, Rentz DM, Sperling RA, Johnson KA (2017) Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline. Ann Neurol 81:583\u2013596. https:\/\/doi.org\/10.1002\/ana.24910","journal-title":"Ann Neurol"},{"key":"664_CR133","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11307-017-1143-1","volume":"20","author":"AK Hansen","year":"2018","unstructured":"Hansen AK, Brooks DJ, Borghammer P (2018) MAO-B inhibitors do not block in vivo Flortaucipir([(18)F]-AV-1451) binding. Mol Imaging Biol 20:356\u2013360. https:\/\/doi.org\/10.1007\/s11307-017-1143-1","journal-title":"Mol Imaging Biol"},{"key":"664_CR134","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/369488a0","volume":"369","author":"A Harada","year":"1994","unstructured":"Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369:488\u2013491. https:\/\/doi.org\/10.1038\/369488a0","journal-title":"Nature"},{"key":"664_CR135","unstructured":"Hayashi ML, Lu J, Driver D, Alvarado A. (2016) Antibodies to tau and uses thereof. Eli Lilly and Company"},{"key":"664_CR136","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","volume":"80","author":"T Hedden","year":"2013","unstructured":"Hedden T, Oh H, Younger AP, Patel TA (2013) Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology 80:1341\u20131348. https:\/\/doi.org\/10.1212\/WNL.0b013e31828ab35d","journal-title":"Neurology"},{"key":"664_CR137","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1089\/hum.2016.087","volume":"27","author":"M Hocquemiller","year":"2016","unstructured":"Hocquemiller M, Giersch L, Audrain M, Parker S, Cartier N (2016) Adeno-associated virus-based gene therapy for CNS diseases. Hum Gene Ther 27:478\u2013496. https:\/\/doi.org\/10.1089\/hum.2016.087","journal-title":"Hum Gene Ther"},{"key":"664_CR138","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/s0042-6989(96)00240-4","volume":"37","author":"PR Hof","year":"1997","unstructured":"Hof PR, Vogt BA, Bouras C, Morrison JH (1997) Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vis Res 37:3609\u20133625. https:\/\/doi.org\/10.1016\/s0042-6989(96)00240-4","journal-title":"Vis Res"},{"key":"664_CR139","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU Hoglinger","year":"2011","unstructured":"Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Muller U, Schellenberg GD (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699\u2013705. https:\/\/doi.org\/10.1038\/ng.859","journal-title":"Nat Genet"},{"key":"664_CR140","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, Ouidja MO, Brodsky FM, Marasa J, Bagchi DP, Kotzbauer PT, Miller TM, Papy-Garcia D, Diamond MI (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A 110:E3138\u2013E3147. https:\/\/doi.org\/10.1073\/pnas.1301440110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR141","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1523\/jneurosci.3191-12.2013","volume":"33","author":"JK Holth","year":"2013","unstructured":"Holth JK, Bomben VC, Reed JG, Inoue T, Younkin L, Younkin SG, Pautler RG, Botas J, Noebels JL (2013) Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J Neurosci 33:1651\u20131659. https:\/\/doi.org\/10.1523\/jneurosci.3191-12.2013","journal-title":"J Neurosci"},{"key":"664_CR142","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2967\/jnumed.117.196741","volume":"59","author":"M Honer","year":"2018","unstructured":"Honer M, Gobbi L, Knust H, Kuwabara H, Muri D, Koerner M, Valentine H, Dannals RF, Wong DF, Borroni E (2018) Preclinical evaluation of (18)F-RO6958948, (11)C-RO6931643, and (11)C-RO6924963 as novel PET radiotracers for imaging tau aggregates in Alzheimer disease. J Nucl Med 59:675\u2013681. https:\/\/doi.org\/10.2967\/jnumed.117.196741","journal-title":"J Nucl Med"},{"key":"664_CR143","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067\u20131081. https:\/\/doi.org\/10.1016\/j.neuron.2010.11.030","journal-title":"Neuron"},{"key":"664_CR144","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/s0002-9440(10)63462-1","volume":"163","author":"T Horiguchi","year":"2003","unstructured":"Horiguchi T, Uryu K, Giasson BI, Ischiropoulos H, LightFoot R, Bellmann C et al (2003) Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 163:1021\u20131031. https:\/\/doi.org\/10.1016\/s0002-9440(10)63462-1","journal-title":"Am J Pathol"},{"key":"664_CR145","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.celrep.2018.04.040","volume":"23","author":"NW Hu","year":"2018","unstructured":"Hu NW, Corbett GT, Moore S, Klyubin I, O'Malley TT, Walsh DM, Livesey FJ, Rowan MJ (2018) Extracellular forms of Abeta and tau from iPSC models of Alzheimer's disease disrupt synaptic plasticity. Cell Rep 23:1932\u20131938. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.040","journal-title":"Cell Rep"},{"key":"664_CR146","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1570-9639(02)00538-1","volume":"1645","author":"Q Hua","year":"2003","unstructured":"Hua Q, He RQ (2003) Tau could protect DNA double helix structure. Biochim Biophys Acta 1645:205\u2013211","journal-title":"Biochim Biophys Acta"},{"key":"664_CR147","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P (1998) Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705. https:\/\/doi.org\/10.1038\/31508","journal-title":"Nature"},{"key":"664_CR148","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.nicl.2017.09.016","volume":"17","author":"L Iaccarino","year":"2018","unstructured":"Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD (2018) Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's disease. Neuroimage Clin 17:452\u2013464. https:\/\/doi.org\/10.1016\/j.nicl.2017.09.016","journal-title":"Neuroimage Clin"},{"key":"664_CR149","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/jneurosci.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J Neurosci 33:1024\u20131037. https:\/\/doi.org\/10.1523\/jneurosci.2642-12.2013","journal-title":"J Neurosci"},{"key":"664_CR150","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.expneurol.2004.06.011","volume":"190","author":"MD Ikonomovic","year":"2004","unstructured":"Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST (2004) Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 190:192\u2013203. https:\/\/doi.org\/10.1016\/j.expneurol.2004.06.011","journal-title":"Exp Neurol"},{"key":"664_CR151","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/jnc.12821","volume":"132","author":"A Ittner","year":"2015","unstructured":"Ittner A, Bertz J, Suh LS, Stevens CH, Gotz J, Ittner LM (2015) Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice. J Neurochem 132:135\u2013145. https:\/\/doi.org\/10.1111\/jnc.12821","journal-title":"J Neurochem"},{"key":"664_CR152","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Gotz J (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142:387\u2013397. https:\/\/doi.org\/10.1016\/j.cell.2010.06.036","journal-title":"Cell"},{"key":"664_CR153","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC (2018) Longitudinal tau PET in ageing and Alzheimer's disease. Brain 141:1517\u20131528. https:\/\/doi.org\/10.1093\/brain\/awy059","journal-title":"Brain"},{"key":"664_CR154","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, Machulda MM, Mielke MM, Roberts RO, Vemuri P, Reyes DA, Petersen RC (2017) Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimers Dement 13:205\u2013216. https:\/\/doi.org\/10.1016\/j.jalz.2016.08.005","journal-title":"Alzheimers Dement"},{"key":"664_CR155","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jamapsychiatry.2017.3391","volume":"75","author":"WJ Jansen","year":"2018","unstructured":"Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleo A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chetelat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonca A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Forster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Kohler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Mollergard HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers I, Rami L, Rodriguez-Rodriguez E, Roe CM, Rot U, Ruther E, Santana I, Schroder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin AK, Wiltfang J, Zetterberg H (2018) Association of Cerebral Amyloid-beta Aggregation with Cognitive Functioning in persons without dementia. JAMA Psychiatry 75:84\u201395. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.3391","journal-title":"JAMA Psychiatry"},{"key":"664_CR156","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00401-010-0654-5","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA, Attems J (2010) Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol 119:421\u2013433. https:\/\/doi.org\/10.1007\/s00401-010-0654-5","journal-title":"Acta Neuropathol"},{"key":"664_CR157","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13195-018-0378-7","volume":"10","author":"M Ji","year":"2018","unstructured":"Ji M, Xie XX, Liu DQ, Yu XL, Zhang Y, Zhang LX, Wang SW, Huang YR, Liu RT (2018) Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia. Alzheimers Res Ther 10:55. https:\/\/doi.org\/10.1186\/s13195-018-0378-7","journal-title":"Alzheimers Res Ther"},{"key":"664_CR158","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1021\/acsmedchemlett.7b00463","volume":"9","author":"XY Jiang","year":"2018","unstructured":"Jiang XY, Chen TK, Zhou JT, He SY, Yang HY, Chen Y, Qu W, Feng F, Sun HP (2018) Dual GSK-3beta\/AChE inhibitors as a new strategy for multitargeting anti-Alzheimer's disease drug discovery. ACS Med Chem Lett 9:171\u2013176. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00463","journal-title":"ACS Med Chem Lett"},{"key":"664_CR159","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128\u2013132","journal-title":"J Neurosci Res"},{"key":"664_CR160","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1046\/j.1471-4159.1997.68010430.x","volume":"68","author":"GV Johnson","year":"1997","unstructured":"Johnson GV, Seubert P, Cox TM, Motter R, Brown JP, Galasko D (1997) The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem 68:430\u2013433","journal-title":"J Neurochem"},{"key":"664_CR161","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K, Marshall G, Albers M, Mauro S, Pepin L, Alverio J, Judge K, Philiossaint M, Shoup T, Yokell D, Dickerson B, Gomez-Isla T, Hyman B, Vasdev N, Sperling R (2016) Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 79:110\u2013119. https:\/\/doi.org\/10.1002\/ana.24546","journal-title":"Ann Neurol"},{"key":"664_CR162","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2017.07.070","volume":"139","author":"M Jouanne","year":"2017","unstructured":"Jouanne M, Rault S, Voisin-Chiret AS (2017) Tau protein aggregation in Alzheimer's disease: an attractive target for the development of novel therapeutic agents. Eur J Med Chem 139:153\u2013167. https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.070","journal-title":"Eur J Med Chem"},{"key":"664_CR163","doi-asserted-by":"publisher","first-page":"10851","DOI":"10.1523\/jneurosci.0387-15.2015","volume":"35","author":"D Kanmert","year":"2015","unstructured":"Kanmert D, Cantlon A, Muratore CR, Jin M, O'Malley TT, Lee G, Young-Pearse TL, Selkoe DJ, Walsh DM (2015) C-terminally truncated forms of tau, but not full-length tau or its C-terminal fragments, are released from neurons independently of cell death. J Neurosci 35:10851\u201310865. https:\/\/doi.org\/10.1523\/jneurosci.0387-15.2015","journal-title":"J Neurosci"},{"key":"664_CR164","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","volume":"23","author":"T Katsinelos","year":"2018","unstructured":"Katsinelos T, Zeitler M, Dimou E, Karakatsani A, Muller HM, Nachman E, Steringer JP, Ruiz de Almodovar C, Nickel W, Jahn TR (2018) Unconventional secretion mediates the trans-cellular spreading of tau. Cell Rep 23:2039\u20132055. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.056","journal-title":"Cell Rep"},{"key":"664_CR165","doi-asserted-by":"publisher","unstructured":"Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI (2012) Trans-cellular propagation of tau aggregation by fibrillar species. J Biol Chem 287:19440\u201319451. https:\/\/doi.org\/10.1074\/jbc.M112.346072","DOI":"10.1074\/jbc.M112.346072"},{"key":"664_CR166","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-510X(02)00410-0","volume":"208","author":"K Kobayashi","year":"2003","unstructured":"Kobayashi K, Nakano H, Hayashi M, Shimazaki M, Fukutani Y, Sasaki K, Sugimori K, Koshino Y (2003) Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J Neurol Sci 208:17\u201324","journal-title":"J Neurol Sci"},{"key":"664_CR167","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/alzrt278","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova E, Zilka N, Kovacech B, Novak P, Novak M (2014) First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model. Alzheimers Res Ther 6:44. https:\/\/doi.org\/10.1186\/alzrt278","journal-title":"Alzheimers Res Ther"},{"key":"664_CR168","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/alzrt277","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova E, Zilka N, Kovacech B, Skrabana R, Novak M (2014) Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease. Alzheimers Res Ther 6:45. https:\/\/doi.org\/10.1186\/alzrt277","journal-title":"Alzheimers Res Ther"},{"key":"664_CR169","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","volume":"83","author":"KS Kosik","year":"1986","unstructured":"Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83:4044\u20134048","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR170","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/0896-6273(89)90077-9","volume":"2","author":"KS Kosik","year":"1989","unstructured":"Kosik KS, Orecchio LD, Bakalis S, Neve RL (1989) Developmentally regulated expression of specific tau sequences. Neuron 2:1389\u20131397","journal-title":"Neuron"},{"key":"664_CR171","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1038\/ncomms8247","volume":"6","author":"N Kouri","year":"2015","unstructured":"Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NC, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, Farlow MR, Grafman J, Huey ED, Ryung Han M, Beecher S, Geller ET, Kretzschmar HA, Roeber S, Gearing M, Juncos JL, Vonsattel JP, Van Deerlin VM, Grossman M, Hurtig HI, Gross RG, Arnold SE, Trojanowski JQ, Lee VM, Wenning GK, White CL, Hoglinger GU, Muller U, Devlin B, Golbe LI, Crook J, Parisi JE, Boeve BF, Josephs KA, Wszolek ZK, Uitti RJ, Graff-Radford NR, Litvan I, Younkin SG, Wang LS, Ertekin-Taner N, Rademakers R, Hakonarsen H, Schellenberg GD, Dickson DW (2015) Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun 6:7247. https:\/\/doi.org\/10.1038\/ncomms8247","journal-title":"Nat Commun"},{"key":"664_CR172","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG (2015) Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41:3\u201323. https:\/\/doi.org\/10.1111\/nan.12208","journal-title":"Neuropathol Appl Neurobiol"},{"key":"664_CR173","doi-asserted-by":"publisher","unstructured":"Kovacs GG (2016) Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine. Int J Mol Sci 17. https:\/\/doi.org\/10.3390\/ijms17020189","DOI":"10.3390\/ijms17020189"},{"key":"664_CR174","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/bpa.12536","volume":"27","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG, Lee VM, Trojanowski JQ (2017) Protein astrogliopathies in human neurodegenerative diseases and aging. Brain pathol 27:675\u2013690. https:\/\/doi.org\/10.1111\/bpa.12536","journal-title":"Brain pathol"},{"key":"664_CR175","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-018-0552-y","volume":"6","author":"GG Kovacs","year":"2018","unstructured":"Kovacs GG, Xie SX, Robinson JL, Lee EB, Smith DH, Schuck T, Lee VM, Trojanowski JQ (2018) Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain. Acta Neuropathol Commun 6:50. https:\/\/doi.org\/10.1186\/s40478-018-0552-y","journal-title":"Acta Neuropathol Commun"},{"key":"664_CR176","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.neuroimage.2017.05.049","volume":"157","author":"MR LaPoint","year":"2017","unstructured":"LaPoint MR, Chhatwal JP, Sepulcre J, Johnson KA, Sperling RA, Schultz AP (2017) The association between tau PET and retrospective cortical thinning in clinically normal elderly. Neuroimage 157:612\u2013622. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.05.049","journal-title":"Neuroimage"},{"key":"664_CR177","doi-asserted-by":"publisher","first-page":"13556","DOI":"10.1038\/s41598-017-13786-2","volume":"7","author":"A Lathuiliere","year":"2017","unstructured":"Lathuiliere A, Valdes P, Papin S, Cacquevel M, Maclachlan C, Knott GW, Muhs A, Paganetti P, Schneider BL (2017) Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects. Sci Rep 7:13556. https:\/\/doi.org\/10.1038\/s41598-017-13786-2","journal-title":"Sci Rep"},{"key":"664_CR178","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/mp.2016.226","volume":"22","author":"K Guennec Le","year":"2017","unstructured":"Le Guennec K, Quenez O, Nicolas G, Wallon D, Rousseau S, Richard AC, Alexander J, Paschou P, Charbonnier C, Bellenguez C, Grenier-Boley B, Lechner D, Bihoreau MT, Olaso R, Boland A, Meyer V, Deleuze JF, Amouyel P, Munter HM, Bourque G, Lathrop M, Frebourg T, Redon R, Letenneur L, Dartigues JF, Martinaud O, Kalev O, Mehrabian S, Traykov L, Strobel T, Le Ber I, Caroppo P, Epelbaum S, Jonveaux T, Pasquier F, Rollin-Sillaire A, Genin E, Guyant-Marechal L, Kovacs GG, Lambert JC, Hannequin D, Campion D, Rovelet-Lecrux A (2017) 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression. Mol Psychiatry 22:1119\u20131125. https:\/\/doi.org\/10.1038\/mp.2016.226","journal-title":"Mol Psychiatry"},{"key":"664_CR179","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1523\/jneurosci.0485-18.2018","volume":"38","author":"SL Leal","year":"2018","unstructured":"Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ (2018) Subthreshold amyloid predicts tau deposition in aging. J Neurosci 38:4482\u20134489. https:\/\/doi.org\/10.1523\/jneurosci.0485-18.2018","journal-title":"J Neurosci"},{"key":"664_CR180","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3233\/jad-170840","volume":"62","author":"CM Lee","year":"2018","unstructured":"Lee CM, Jacobs HIL, Marquie M, Becker JA, Andrea NV, Jin DS, Schultz AP, Frosch MP, Gomez-Isla T, Sperling RA, Johnson KA (2018) 18F-Flortaucipir binding in choroid plexus: related to race and Hippocampus signal. J Alzheimers Dis 62:1691\u20131702. https:\/\/doi.org\/10.3233\/jad-170840","journal-title":"J Alzheimers Dis"},{"key":"664_CR181","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","volume":"105","author":"MJ Lee","year":"2013","unstructured":"Lee MJ, Lee JH, Rubinsztein DC (2013) Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105:49\u201359. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.03.001","journal-title":"Prog Neurobiol"},{"key":"664_CR182","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.celrep.2016.06.099","volume":"16","author":"SH Lee","year":"2016","unstructured":"Lee SH, Le Pichon CE, Adolfsson O, Gafner V, Pihlgren M, Lin H, Solanoy H, Brendza R, Ngu H, Foreman O, Chan R, Ernst JA, DiCara D, Hotzel I, Srinivasan K, Hansen DV, Atwal J, Lu Y, Bumbaca D, Pfeifer A, Watts RJ, Muhs A, Scearce-Levie K, Ayalon G (2016) Antibody-mediated targeting of tau in vivo does not require effector function and microglial engagement. Cell Rep 16:1690\u20131700. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.099","journal-title":"Cell Rep"},{"key":"664_CR183","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1899488","volume":"251","author":"VM Lee","year":"1991","unstructured":"Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675\u2013678","journal-title":"Science"},{"key":"664_CR184","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121\u20131159. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.1121","journal-title":"Annu Rev Neurosci"},{"key":"664_CR185","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.2613","volume":"18","author":"P Lei","year":"2012","unstructured":"Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK et al (2012) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18:291\u2013295. https:\/\/doi.org\/10.1038\/nm.2613","journal-title":"Nat Med"},{"key":"664_CR186","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1750-1326-9-29","volume":"9","author":"P Lei","year":"2014","unstructured":"Lei P, Ayton S, Moon S, Zhang Q, Volitakis I, Finkelstein DI, Bush AI (2014) Motor and cognitive deficits in aged tau knockout mice in two background strains. Mol Neurodegener 9:29. https:\/\/doi.org\/10.1186\/1750-1326-9-29","journal-title":"Mol Neurodegener"},{"key":"664_CR187","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.dadm.2018.01.007","volume":"10","author":"L Lemoine","year":"2018","unstructured":"Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A (2018) Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding. Alzheimers Dement (Amst) 10:232\u2013236. https:\/\/doi.org\/10.1016\/j.dadm.2018.01.007","journal-title":"Alzheimers Dement (Amst)"},{"key":"664_CR188","doi-asserted-by":"publisher","first-page":"165ra163","DOI":"10.1126\/scitranslmed.3003454","volume":"4","author":"P Leone","year":"2012","unstructured":"Leone P, Shera D, McPhee SW, Francis JS, Kolodny EH, Bilaniuk LT, Wang DJ, Assadi M, Goldfarb O, Goldman HW, Freese A, Young D, During MJ, Samulski RJ, Janson CG (2012) Long-term follow-up after gene therapy for canavan disease. Sci Transl Med 4:165ra163. https:\/\/doi.org\/10.1126\/scitranslmed.3003454","journal-title":"Sci Transl Med"},{"key":"664_CR189","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"C Li","year":"2017","unstructured":"Li C, Gotz J (2017) Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov 16:863\u2013883. https:\/\/doi.org\/10.1038\/nrd.2017.155","journal-title":"Nat Rev Drug Discov"},{"key":"664_CR190","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.tips.2018.09.001","volume":"39","author":"D Li","year":"2018","unstructured":"Li D, Mastaglia FL, Fletcher S, Wilton SD (2018) Precision medicine through antisense oligonucleotide-mediated exon skipping. Trends Pharmacol Sci 39:982\u2013994. https:\/\/doi.org\/10.1016\/j.tips.2018.09.001","journal-title":"Trends Pharmacol Sci"},{"key":"664_CR191","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.neurobiolaging.2014.05.001","volume":"35","author":"Z Li","year":"2014","unstructured":"Li Z, Hall AM, Kelinske M, Roberson ED (2014) Seizure resistance without parkinsonism in aged mice after tau reduction. Neurobiol Aging 35:2617\u20132624. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.05.001","journal-title":"Neurobiol Aging"},{"key":"664_CR192","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1016\/S0021-9258(20)71345-1","volume":"259","author":"G Lindwall","year":"1984","unstructured":"Lindwall G, Cole RD (1984) The purification of tau protein and the occurrence of two phosphorylation states of tau in brain. J Biol Chem 259:12241\u201312245","journal-title":"J Biol Chem"},{"key":"664_CR193","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/brain\/aww256","volume":"139","author":"H Ling","year":"2016","unstructured":"Ling H, Kovacs GG, Vonsattel JP, Davey K, Mok KY, Hardy J, Morris HR, Warner TT, Holton JL, Revesz T (2016) Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain 139:3237\u20133252. https:\/\/doi.org\/10.1093\/brain\/aww256","journal-title":"Brain"},{"key":"664_CR194","doi-asserted-by":"publisher","unstructured":"Liu C, Song X, Nisbet R, Gotz J (2016) Co-immunoprecipitation with tau isoform-specific antibodies reveals distinct protein interactions and highlights a putative role for 2N tau in disease. J Biol Chem 291:8173\u20138188. https:\/\/doi.org\/10.1074\/jbc.M115.641902","DOI":"10.1074\/jbc.M115.641902"},{"key":"664_CR195","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-3-8","volume":"3","author":"F Liu","year":"2008","unstructured":"Liu F, Gong CX (2008) Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 3:8. https:\/\/doi.org\/10.1186\/1750-1326-3-8","journal-title":"Mol Neurodegener"},{"key":"664_CR196","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0014-5793(02)02228-7","volume":"512","author":"F Liu","year":"2002","unstructured":"Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Merkle RK, Gong CX (2002) Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease. FEBS Lett 512:101\u2013106","journal-title":"FEBS Lett"},{"key":"664_CR197","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7:e31302. https:\/\/doi.org\/10.1371\/journal.pone.0031302","journal-title":"PLoS One"},{"key":"664_CR198","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroimage.2017.02.051","volume":"150","author":"SN Lockhart","year":"2017","unstructured":"Lockhart SN, Sch\u00f6ll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ (2017) Amyloid and tau PET demonstrate region-specific associations in normal older people. Neuroimage 150:191\u2013199. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.02.051","journal-title":"Neuroimage"},{"key":"664_CR199","doi-asserted-by":"publisher","unstructured":"Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas-Valenzuela C, Declercq R, Reynders T, Telan-Choing F, Riffel K, Celen S, Serdons K, Bormans G, Tsai K, Walji A, Hostetler ED, Evelhoch JL, Van Laere K, Forman M, Stoch A, Sur C, Struyk A (2018) First-in-human brain imaging of Alzheimer dementia patients and elderly controls with (18)F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.118.208215","DOI":"10.2967\/jnumed.118.208215"},{"key":"664_CR200","doi-asserted-by":"publisher","unstructured":"Lois C, Gonzalez I, Johnson KA, Price JC (2018) PET imaging of tau protein targets: a methodology perspective. Brain Imaging Behav. https:\/\/doi.org\/10.1007\/s11682-018-9847-7","DOI":"10.1007\/s11682-018-9847-7"},{"key":"664_CR201","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1073\/pnas.87.21.8422","volume":"87","author":"PA Loomis","year":"1990","unstructured":"Loomis PA, Howard TH, Castleberry RP, Binder LI (1990) Identification of nuclear tau isoforms in human neuroblastoma cells. Proc Natl Acad Sci U S A 87:8422\u20138426","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR202","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","volume":"19","author":"CL Lorson","year":"2010","unstructured":"Lorson CL, Rindt H, Shababi M (2010) Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet 19:R111\u2013R118. https:\/\/doi.org\/10.1093\/hmg\/ddq147","journal-title":"Hum Mol Genet"},{"key":"664_CR203","first-page":"7","volume":"6","author":"DR Love","year":"1989","unstructured":"Love DR, Davies KE (1989) Duchenne muscular dystrophy: the gene and the protein. Mol Biol Med 6:7\u201317","journal-title":"Mol Biol Med"},{"key":"664_CR204","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.dadm.2018.01.005","volume":"10","author":"VJ Lowe","year":"2018","unstructured":"Lowe VJ, Bruinsma TJ, Min HK, Lundt ES, Fang P, Senjem ML, Boeve BF, Josephs KA, Pandey MK, Murray ME, Kantarci K, Jones DT, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr (2018) Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants. Alzheimers Dement (Amst) 10:210\u2013216. https:\/\/doi.org\/10.1016\/j.dadm.2018.01.005","journal-title":"Alzheimers Dement (Amst)"},{"key":"664_CR205","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T, Knopman DS, Jones DT, Petrucelli L, Cook CN, Graff-Radford NR, Dickson DW, Petersen RC, Jack CR Jr, Murray ME (2016) An autoradiographic evaluation of AV-1451 tau PET in dementia. Acta Neuropathol Commun 4:58. https:\/\/doi.org\/10.1186\/s40478-016-0315-6","journal-title":"Acta Neuropathol Commun"},{"key":"664_CR206","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/brain\/awx320","volume":"141","author":"VJ Lowe","year":"2018","unstructured":"Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr (2018) Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. Brain 141:271\u2013287. https:\/\/doi.org\/10.1093\/brain\/awx320","journal-title":"Brain"},{"key":"664_CR207","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JAD-2007-12410","volume":"12","author":"J Luna-Munoz","year":"2007","unstructured":"Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, Mena R (2007) Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. J Alzheimers Dis 12:365\u2013375","journal-title":"J Alzheimers Dis"},{"key":"664_CR208","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-2005-8104","volume":"8","author":"J Luna-Munoz","year":"2005","unstructured":"Luna-Munoz J, Garcia-Sierra F, Falcon V, Menendez I, Chavez-Macias L, Mena R (2005) Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. J Alzheimers Dis 8:29\u201341","journal-title":"J Alzheimers Dis"},{"key":"664_CR209","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1073\/pnas.1417548111","volume":"111","author":"HB Luo","year":"2014","unstructured":"Luo HB, Xia YY, Shu XJ, Liu ZC, Feng Y, Liu XH et al (2014) SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc Natl Acad Sci U S A 111:16586\u201316591. https:\/\/doi.org\/10.1073\/pnas.1417548111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR210","doi-asserted-by":"publisher","first-page":"11161","DOI":"10.1038\/srep11161","volume":"5","author":"W Luo","year":"2015","unstructured":"Luo W, Liu W, Hu X, Hanna M, Caravaca A, Paul SM (2015) Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody. Sci Rep 5:11161. https:\/\/doi.org\/10.1038\/srep11161","journal-title":"Sci Rep"},{"key":"664_CR211","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","volume":"157","author":"A Maass","year":"2017","unstructured":"Maass A, Landau S, Baker SL, Horng A, Lockhart SN, La Joie R, Rabinovici GD, Jagust WJ (2017) Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease. Neuroimage 157:448\u2013463. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.05.058","journal-title":"Neuroimage"},{"key":"664_CR212","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/jneurosci.2028-17.2017","volume":"38","author":"A Maass","year":"2018","unstructured":"Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust WJ (2018) Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J Neurosci 38:530\u2013543. https:\/\/doi.org\/10.1523\/jneurosci.2028-17.2017","journal-title":"J Neurosci"},{"key":"664_CR213","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1038\/sj.emboj.7601878","volume":"26","author":"E Magnani","year":"2007","unstructured":"Magnani E, Fan J, Gasparini L, Golding M, Williams M, Schiavo G, Goedert M, Amos LA, Spillantini MG (2007) Interaction of tau protein with the dynactin complex. EMBO J 26:4546\u20134554. https:\/\/doi.org\/10.1038\/sj.emboj.7601878","journal-title":"EMBO J"},{"key":"664_CR214","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0014-5793(98)00910-7","volume":"433","author":"C Mailliot","year":"1998","unstructured":"Mailliot C, Sergeant N, Bussiere T, Caillet-Boudin ML, Delacourte A, Buee L (1998) Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 433:201\u2013204","journal-title":"FEBS Lett"},{"key":"664_CR215","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","volume":"107","author":"DL Mallery","year":"2010","unstructured":"Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC (2010) Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci U S A 107:19985\u201319990. https:\/\/doi.org\/10.1073\/pnas.1014074107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR216","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM, Lamb BT, Bhaskar K (2015) Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138:1738\u20131755. https:\/\/doi.org\/10.1093\/brain\/awv081","journal-title":"Brain"},{"key":"664_CR217","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejmech.2015.10.018","volume":"107","author":"M Maqbool","year":"2016","unstructured":"Maqbool M, Mobashir M, Hoda N (2016) Pivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer's disease. Eur J Med Chem 107:63\u201381. https:\/\/doi.org\/10.1016\/j.ejmech.2015.10.018","journal-title":"Eur J Med Chem"},{"key":"664_CR218","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1084\/jem.20161731","volume":"214","author":"E Marciniak","year":"2017","unstructured":"Marciniak E, Leboucher A, Caron E, Ahmed T, Tailleux A, Dumont J, Issad T, Gerhardt E, Pagesy P, Vileno M, Bournonville C, Hamdane M, Bantubungi K, Lancel S, Demeyer D, Eddarkaoui S, Vallez E, Vieau D, Humez S, Faivre E, Grenier-Boley B, Outeiro TF, Staels B, Amouyel P, Balschun D, Buee L, Blum D (2017) Tau deletion promotes brain insulin resistance. J Exp Med 214:2257\u20132269. https:\/\/doi.org\/10.1084\/jem.20161731","journal-title":"J Exp Med"},{"key":"664_CR219","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marquie","year":"2015","unstructured":"Marquie M, Normandin MD, Vanderburg CR, Costantino IM, Bien EA, Rycyna LG, Klunk WE, Mathis CA, Ikonomovic MD, Debnath ML, Vasdev N, Dickerson BC, Gomperts SN, Growdon JH, Johnson KA, Frosch MP, Hyman BT, Gomez-Isla T (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787\u2013800. https:\/\/doi.org\/10.1002\/ana.24517","journal-title":"Ann Neurol"},{"key":"664_CR220","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00401-017-1740-8","volume":"134","author":"M Marquie","year":"2017","unstructured":"Marquie M, Siao Tick Chong M, Anton-Fernandez A, Verwer EE, Saez-Calveras N, Meltzer AC, Ramanan P, Amaral AC, Gonzalez J, Normandin MD, Frosch MP, Gomez-Isla T (2017) [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging. Acta Neuropathol 134:619\u2013628. https:\/\/doi.org\/10.1007\/s00401-017-1740-8","journal-title":"Acta Neuropathol"},{"key":"664_CR221","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","volume":"5","author":"M Marquie","year":"2017","unstructured":"Marquie M, Verwer EE, Meltzer AC, Kim SJW, Aguero C, Gonzalez J, Makaretz SJ, Siao Tick Chong M, Ramanan P, Amaral AC, Normandin MD, Vanderburg CR, Gomperts SN, Johnson KA, Frosch MP, Gomez-Isla T (2017) Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case. Acta Neuropathol Commun 5:75. https:\/\/doi.org\/10.1186\/s40478-017-0482-0","journal-title":"Acta Neuropathol Commun"},{"key":"664_CR222","doi-asserted-by":"publisher","unstructured":"McClorey G, Banerjee S (2018) Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics. Biomedicines 6. https:\/\/doi.org\/10.3390\/biomedicines6020051","DOI":"10.3390\/biomedicines6020051"},{"key":"664_CR223","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1073\/pnas.1607215114","volume":"114","author":"WA McEwan","year":"2017","unstructured":"McEwan WA, Falcon B, Vaysburd M, Clift D, Oblak AL, Ghetti B, Goedert M, James LC (2017) Cytosolic fc receptor TRIM21 inhibits seeded tau aggregation. Proc Natl Acad Sci U S A 114:574\u2013579. https:\/\/doi.org\/10.1073\/pnas.1607215114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR224","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuron.2018.01.022","volume":"97","author":"J McInnes","year":"2018","unstructured":"McInnes J, Wierda K, Snellinx A, Bounti L, Wang YC, Stancu IC, Apostolo N, Gevaert K, Dewachter I, Spires-Jones TL, De Strooper B, De Wit J, Zhou L, Verstreken P (2018) Synaptogyrin-3 mediates presynaptic dysfunction induced by tau. Neuron 97:823\u2013835.e828. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.022","journal-title":"Neuron"},{"key":"664_CR225","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1523\/jneurosci.3029-15.2016","volume":"36","author":"S Meier","year":"2016","unstructured":"Meier S, Bell M, Lyons DN, Rodriguez-Rivera J, Ingram A, Fontaine SN, Mechas E, Chen J, Wolozin B, LeVine H 3rd, Zhu H, Abisambra JF (2016) Pathological tau promotes neuronal damage by impairing ribosomal function and decreasing protein synthesis. J Neurosci 36:1001\u20131007. https:\/\/doi.org\/10.1523\/jneurosci.3029-15.2016","journal-title":"J Neurosci"},{"key":"664_CR226","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1021\/cn5003013","volume":"6","author":"P Melnyk","year":"2015","unstructured":"Melnyk P, Vingtdeux V, Burlet S, Eddarkaoui S, Grosjean ME, Larchanche PE, Hochart G, Sergheraert C, Estrella C, Barrier M, Poix V, Plancq P, Lannoo C, Hamdane M, Delacourte A, Verwaerde P, Buee L, Sergeant N (2015) Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid peptide precursor metabolism. ACS Chem Neurosci 6:559\u2013569. https:\/\/doi.org\/10.1021\/cn5003013","journal-title":"ACS Chem Neurosci"},{"key":"664_CR227","doi-asserted-by":"crossref","unstructured":"Mignon L, Kordasiewicz H, Lane R, Smith A, Miller T, Narayanan P, Swayze EN, D., Fitzsimmons B, Bennett F (2018) Design of the First-in-Human Study of IONIS-MAPTRx, a Tau-lowering Antisense Oligonucleotide, in Patients With Alzheimer Disease (S2.006). Neurology 90; S2.006.","DOI":"10.1212\/WNL.90.15_supplement.S2.006"},{"key":"664_CR228","doi-asserted-by":"publisher","unstructured":"Mirbaha H, Chen D, Morazova OA, Ruff KM, Sharma AM, Liu X, Goodarzi M, Pappu RV, Colby DW, Mirzaei H, Joachimiak LA, Diamond MI (2018) Inert and seed-competent tau monomers suggest structural origins of aggregation. Elife 7. https:\/\/doi.org\/10.7554\/eLife.36584","DOI":"10.7554\/eLife.36584"},{"key":"664_CR229","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuroimage.2017.07.050","volume":"161","author":"S Mishra","year":"2017","unstructured":"Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, Hornbeck R, Balota DA, Cairns NJ, Morris JC, Ances BM, Benzinger TLS (2017) AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure. NeuroImage 161:171\u2013178. https:\/\/doi.org\/10.1016\/j.neuroimage.2017.07.050","journal-title":"NeuroImage"},{"key":"664_CR230","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.neurobiolaging.2012.12.003","volume":"34","author":"M Morris","year":"2013","unstructured":"Morris M, Hamto P, Adame A, Devidze N, Masliah E, Mucke L (2013) Age-appropriate cognition and subtle dopamine-independent motor deficits in aged tau knockout mice. Neurobiol Aging 34:1523\u20131529. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.12.003","journal-title":"Neurobiol Aging"},{"key":"664_CR231","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","volume":"5","author":"A Mudher","year":"2017","unstructured":"Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Alavi Naini SM, Mandelkow EM, Mandelkow E, Buee L, Goedert M, Brion JP (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99. https:\/\/doi.org\/10.1186\/s40478-017-0488-7","journal-title":"Acta Neuropathol Commun"},{"key":"664_CR232","doi-asserted-by":"publisher","unstructured":"Mukrasch MD, von Bergen M, Biernat J, Fischer D, Griesinger C, Mandelkow E, Zweckstetter M (2007) The \u201cjaws\u201d of the tau-microtubule interaction. J Biol Chem 282:12230\u201312239. https:\/\/doi.org\/10.1074\/jbc.M607159200","DOI":"10.1074\/jbc.M607159200"},{"key":"664_CR233","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.nbd.2006.10.018","volume":"25","author":"AJ Myers","year":"2007","unstructured":"Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25:561\u2013570. https:\/\/doi.org\/10.1016\/j.nbd.2006.10.018","journal-title":"Neurobiol Dis"},{"key":"664_CR234","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(sici)1099-1352(199909\/10)12:5<279::Aid-jmr473>3.0.Co;2-3","volume":"12","author":"DG Myszka","year":"1999","unstructured":"Myszka DG (1999) Improving biosensor analysis. J Mol Recognit 12:279\u2013284. https:\/\/doi.org\/10.1002\/(sici)1099-1352(199909\/10)12:5<279::Aid-jmr473>3.0.Co;2-3","journal-title":"J Mol Recognit"},{"key":"664_CR235","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0006-3495(98)77549-6","volume":"75","author":"DG Myszka","year":"1998","unstructured":"Myszka DG, He X, Dembo M, Morton TA, Goldstein B (1998) Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data. Biophys J 75:583\u2013594. https:\/\/doi.org\/10.1016\/s0006-3495(98)77549-6","journal-title":"Biophys J"},{"key":"664_CR236","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1523\/jneurosci.1230-17.2017","volume":"37","author":"S Narasimhan","year":"2017","unstructured":"Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY (2017) Pathological tau strains from human brains recapitulate the diversity of Tauopathies in nontransgenic mouse brain. J Neurosci 37:11406\u201311423. https:\/\/doi.org\/10.1523\/jneurosci.1230-17.2017","journal-title":"J Neurosci"},{"key":"664_CR237","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71:362\u2013381. https:\/\/doi.org\/10.1097\/NEN.0b013e31825018f7","journal-title":"J Neuropathol Exp Neurol"},{"key":"664_CR238","first-page":"271","volume":"387","author":"RL Neve","year":"1986","unstructured":"Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA (1986) Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res 387:271\u2013280","journal-title":"Brain Res"},{"key":"664_CR239","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","volume":"9","author":"KP Ng","year":"2017","unstructured":"Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, Guiot MC, Guo Q, Harada R, Comley RA, Massarweh G, Soucy JP, Okamura N, Gauthier S, Rosa-Neto P (2017) Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain. Alzheimers Res Ther 9:25. https:\/\/doi.org\/10.1186\/s13195-017-0253-y","journal-title":"Alzheimers Res Ther"},{"key":"664_CR240","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ajpath.2017.01.022","volume":"187","author":"CK Nobuhara","year":"2017","unstructured":"Nobuhara CK, DeVos SL, Commins C, Wegmann S, Moore BD, Roe AD, Costantino I, Frosch MP, Pitstick R, Carlson GA, Hock C, Nitsch RM, Montrasio F, Grimm J, Cheung AE, Dunah AW, Wittmann M, Bussiere T, Weinreb PH, Hyman BT, Takeda S (2017) Tau antibody targeting pathological species blocks neuronal uptake and interneuron propagation of tau in vitro. Am J Pathol 187:1399\u20131412. https:\/\/doi.org\/10.1016\/j.ajpath.2017.01.022","journal-title":"Am J Pathol"},{"key":"664_CR241","first-page":"173","volume":"38","author":"M Novak","year":"1994","unstructured":"Novak M (1994) Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol 38:173\u2013189","journal-title":"Acta Virol"},{"key":"664_CR242","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/j.1460-2075.1993.tb05665.x","volume":"12","author":"M Novak","year":"1993","unstructured":"Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12:365\u2013370","journal-title":"EMBO J"},{"key":"664_CR243","doi-asserted-by":"publisher","first-page":"S535","DOI":"10.3233\/jad-179942","volume":"64","author":"P Novak","year":"2018","unstructured":"Novak P, Cehlar O, Skrabana R, Novak M (2018) Tau conformation as a target for disease-modifying therapy: the role of truncation. J Alzheimers Dis 64:S535\u2013s546. https:\/\/doi.org\/10.3233\/jad-179942","journal-title":"J Alzheimers Dis"},{"key":"664_CR244","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fnins.2018.00798","volume":"12","author":"P Novak","year":"2018","unstructured":"Novak P, Kontsekova E, Zilka N, Novak M (2018) Ten years of tau-targeted immunotherapy: the path walked and the roads ahead. Front Neurosci 12:798. https:\/\/doi.org\/10.3389\/fnins.2018.00798","journal-title":"Front Neurosci"},{"key":"664_CR245","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s1474-4422(16)30331-3","volume":"16","author":"P Novak","year":"2017","unstructured":"Novak P, Schmidt R, Kontsekova E, Zilka N, Kovacech B, Skrabana R, Vince-Kazmerova Z, Katina S, Fialova L, Prcina M, Parrak V, Dal-Bianco P, Brunner M, Staffen W, Rainer M, Ondrus M, Ropele S, Smisek M, Sivak R, Winblad B, Novak M (2017) Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Neurol 16:123\u2013134. https:\/\/doi.org\/10.1016\/s1474-4422(16)30331-3","journal-title":"Lancet Neurol"},{"key":"664_CR246","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1016\/j.bmcl.2016.08.092","volume":"26","author":"M Okuda","year":"2016","unstructured":"Okuda M, Hijikuro I, Fujita Y, Teruya T, Kawakami H, Takahashi T, Sugimoto H (2016) Design and synthesis of curcumin derivatives as tau and amyloid beta dual aggregation inhibitors. Bioorg Med Chem Lett 26:5024\u20135028. https:\/\/doi.org\/10.1016\/j.bmcl.2016.08.092","journal-title":"Bioorg Med Chem Lett"},{"key":"664_CR247","doi-asserted-by":"publisher","first-page":"e0117511","DOI":"10.1371\/journal.pone.0117511","volume":"10","author":"M Okuda","year":"2015","unstructured":"Okuda M, Hijikuro I, Fujita Y, Wu X, Nakayama S, Sakata Y, Noguchi Y, Ogo M, Akasofu S, Ito Y, Soeda Y, Tsuchiya N, Tanaka N, Takahashi T, Sugimoto H (2015) PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo. PLoS One 10:e0117511. https:\/\/doi.org\/10.1371\/journal.pone.0117511","journal-title":"PLoS One"},{"key":"664_CR248","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K (2005) Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51:336\u2013345. https:\/\/doi.org\/10.1373\/clinchem.2004.039347","journal-title":"Clin Chem"},{"key":"664_CR249","unstructured":"Ono Mea., et al. Development of novel tau PET tracers, [18F]AM-PPB3 and [18F]PM-PPB3. In: Human Amyloid Imaging Meeting, 2017. p 34"},{"key":"664_CR250","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Sch\u00f6ll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 139:1551\u20131567. https:\/\/doi.org\/10.1093\/brain\/aww027","journal-title":"Brain"},{"key":"664_CR251","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.bcp.2009.04.034","volume":"78","author":"M Oz","year":"2009","unstructured":"Oz M, Lorke DE, Petroianu GA (2009) Methylene blue and Alzheimer's disease. Biochem Pharmacol 78:927\u2013932. https:\/\/doi.org\/10.1016\/j.bcp.2009.04.034","journal-title":"Biochem Pharmacol"},{"key":"664_CR252","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuint.2010.04.013","volume":"57","author":"V Padmaraju","year":"2010","unstructured":"Padmaraju V, Indi SS, Rao KS (2010) New evidences on tau-DNA interactions and relevance to neurodegeneration. Neurochem Int 57:51\u201357. https:\/\/doi.org\/10.1016\/j.neuint.2010.04.013","journal-title":"Neurochem Int"},{"key":"664_CR253","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1021\/acs.jmedchem.7b00395","volume":"60","author":"V Palomo","year":"2017","unstructured":"Palomo V, Perez DI, Roca C, Anderson C, Rodriguez-Muela N, Perez C, Morales-Garcia JA, Reyes JA, Campillo NE, Perez-Castillo AM, Rubin LL, Timchenko L, Gil C, Martinez A (2017) Subtly modulating glycogen synthase kinase 3 beta: allosteric inhibitor development and their potential for the treatment of chronic diseases. J Med Chem 60:4983\u20135001. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00395","journal-title":"J Med Chem"},{"key":"664_CR254","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1021\/acschemneuro.7b00461","volume":"9","author":"D Panek","year":"2018","unstructured":"Panek D, Wieckowska A, Jonczyk J, Godyn J, Bajda M, Wichur T, Pasieka A, Knez D, Pislar A, Korabecny J, Soukup O, Sepsova V, Sabate R, Kos J, Gobec S, Malawska B (2018) Design, synthesis, and biological evaluation of 1-Benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer's agents. ACS Chem Neurosci 9:1074\u20131094. https:\/\/doi.org\/10.1021\/acschemneuro.7b00461","journal-title":"ACS Chem Neurosci"},{"key":"664_CR255","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","volume":"10","author":"TA Pascoal","year":"2018","unstructured":"Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, Bennacef I, Therriault J, Ng KP, Hopewell R, Bouhachi R, Hsiao HH, Benedet AL, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P (2018) In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240. Alzheimers Res Ther 10:74. https:\/\/doi.org\/10.1186\/s13195-018-0402-y","journal-title":"Alzheimers Res Ther"},{"key":"664_CR256","doi-asserted-by":"publisher","unstructured":"Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, Ward S, Reyes JF, Philibert K, Glucksman MJ, Binder LI (2011) Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease. J Biol Chem 286:23063\u201323076. https:\/\/doi.org\/10.1074\/jbc.M111.237974","DOI":"10.1074\/jbc.M111.237974"},{"key":"664_CR257","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1021\/bi002961w","volume":"40","author":"M P\u00e9rez","year":"2001","unstructured":"P\u00e9rez M, Arrasate M, Montejo De Garcini E, Munoz V, Avila J (2001) In vitro assembly of tau protein: mapping the regions involved in filament formation. Biochemistry 40:5983\u20135991","journal-title":"Biochemistry"},{"key":"664_CR258","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1046\/j.1471-4159.1996.67031183.x","volume":"67","author":"M P\u00e9rez","year":"1996","unstructured":"P\u00e9rez M, Valpuesta JM, Medina M, Montejo de Garcini E, Avila J (1996) Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem 67:1183\u20131190","journal-title":"J Neurochem"},{"key":"664_CR259","doi-asserted-by":"publisher","first-page":"965","DOI":"10.4155\/fmc-2017-0049","volume":"9","author":"FJ Perez-Areales","year":"2017","unstructured":"Perez-Areales FJ, Betari N, Viayna A, Pont C, Espargaro A, Bartolini M, De Simone A, Rinaldi Alvarenga JF, Perez B, Sabate R, Lamuela-Raventos RM, Andrisano V, Luque FJ, Munoz-Torrero D (2017) Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein-huprine hybrids. Future Med Chem 9:965\u2013981. https:\/\/doi.org\/10.4155\/fmc-2017-0049","journal-title":"Future Med Chem"},{"key":"664_CR260","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/jmg.2005.031377","volume":"42","author":"AM Pittman","year":"2005","unstructured":"Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, Marlowe L, Duckworth J, Leung D, Williams D, Kilford L, Thomas N, Morris CM, Dickson D, Wood NW, Hardy J, Lees AJ, de Silva R (2005) Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet 42:837\u2013846. https:\/\/doi.org\/10.1136\/jmg.2005.031377","journal-title":"J Med Genet"},{"key":"664_CR261","doi-asserted-by":"publisher","first-page":"e36873","DOI":"10.1371\/journal.pone.0036873","volume":"7","author":"V Plouffe","year":"2012","unstructured":"Plouffe V, Mohamed NV, Rivest-McGraw J, Bertrand J, Lauzon M, Leclerc N (2012) Hyperphosphorylation and cleavage at D421 enhance tau secretion. PLoS One 7:e36873. https:\/\/doi.org\/10.1371\/journal.pone.0036873","journal-title":"PLoS One"},{"key":"664_CR262","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/brain\/aww334","volume":"140","author":"MJ Pontecorvo","year":"2017","unstructured":"Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA (2017) Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain 140:748\u2013763. https:\/\/doi.org\/10.1093\/brain\/aww334","journal-title":"Brain"},{"key":"664_CR263","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler AM, Phillips EC, Lau DH, Noble W, Hanger DP (2013) Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep 14:389\u2013394. https:\/\/doi.org\/10.1038\/embor.2013.15","journal-title":"EMBO Rep"},{"key":"664_CR264","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/molecules21040466","volume":"21","author":"F Prati","year":"2016","unstructured":"Prati F, Cavalli A, Bolognesi ML (2016) Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease. Molecules 21:466. https:\/\/doi.org\/10.3390\/molecules21040466","journal-title":"Molecules"},{"key":"664_CR265","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/anie.201410456","volume":"54","author":"F Prati","year":"2015","unstructured":"Prati F, De Simone A, Bisignano P, Armirotti A, Summa M, Pizzirani D, Scarpelli R, Perez DI, Andrisano V, Perez-Castillo A, Monti B, Massenzio F, Polito L, Racchi M, Favia AD, Bottegoni G, Martinez A, Bolognesi ML, Cavalli A (2015) Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3beta inhibitors. Angew Chem Int Ed Engl 54:1578\u20131582. https:\/\/doi.org\/10.1002\/anie.201410456","journal-title":"Angew Chem Int Ed Engl"},{"key":"664_CR266","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1021\/bi5014613","volume":"54","author":"H Qi","year":"2015","unstructured":"Qi H, Cantrelle FX, Benhelli-Mokrani H, Smet-Nocca C, Buee L, Lippens G, Bonnefoy E, Galas MC, Landrieu I (2015) Nuclear magnetic resonance spectroscopy characterization of interaction of tau with DNA and its regulation by phosphorylation. Biochemistry 54:1525\u20131533. https:\/\/doi.org\/10.1021\/bi5014613","journal-title":"Biochemistry"},{"key":"664_CR267","first-page":"2723","volume":"15","author":"MH Qu","year":"2004","unstructured":"Qu MH, Li H, Tian R, Nie CL, Liu Y, Han BS, He RQ (2004) Neuronal tau induces DNA conformational changes observed by atomic force microscopy. Neuroreport 15:2723\u20132727","journal-title":"Neuroreport"},{"key":"664_CR268","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","volume":"75","author":"YT Quiroz","year":"2018","unstructured":"Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, Johnson KA (2018) Association between amyloid and tau accumulation in Young adults with autosomal dominant Alzheimer disease. JAMA Neurol 75:548\u2013556. https:\/\/doi.org\/10.1001\/jamaneurol.2017.4907","journal-title":"JAMA Neurol"},{"key":"664_CR269","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/brain\/awp326","volume":"133","author":"GD Rabinovici","year":"2010","unstructured":"Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ (2010) Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 133:512\u2013528. https:\/\/doi.org\/10.1093\/brain\/awp326","journal-title":"Brain"},{"key":"664_CR270","doi-asserted-by":"publisher","first-page":"17034","DOI":"10.1038\/s41598-017-17313-1","volume":"7","author":"H Rajamohamedsait","year":"2017","unstructured":"Rajamohamedsait H, Rasool S, Rajamohamedsait W, Lin Y, Sigurdsson EM (2017) Prophylactic active tau immunization leads to sustained reduction in both tau and amyloid-beta pathologies in 3xTg mice. Sci Rep 7:17034. https:\/\/doi.org\/10.1038\/s41598-017-17313-1","journal-title":"Sci Rep"},{"key":"664_CR271","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.ajpath.2011.01.030","volume":"178","author":"JF Reyes","year":"2011","unstructured":"Reyes JF, Fu Y, Vana L, Kanaan NM, Binder LI (2011) Tyrosine nitration within the proline-rich region of tau in Alzheimer's disease. Am J Pathol 178:2275\u20132285. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.030","journal-title":"Am J Pathol"},{"key":"664_CR272","doi-asserted-by":"publisher","first-page":"10636","DOI":"10.1523\/jneurosci.2143-06.2006","volume":"26","author":"MR Reynolds","year":"2006","unstructured":"Reynolds MR, Reyes JF, Fu Y, Bigio EH, Guillozet-Bongaarts AL, Berry RW, Binder LI (2006) Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. J Neurosci 26:10636\u201310645. https:\/\/doi.org\/10.1523\/jneurosci.2143-06.2006","journal-title":"J Neurosci"},{"key":"664_CR273","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/psc.2518","volume":"19","author":"M Richter","year":"2013","unstructured":"Richter M, Hoffmann R, Singer D (2013) T-cell epitope-dependent immune response in inbred (C57BL\/6J, SJL\/J, and C3H\/HeN) and transgenic P301S and Tg2576 mice. J Pept Sci 19:441\u2013451. https:\/\/doi.org\/10.1002\/psc.2518","journal-title":"J Pept Sci"},{"key":"664_CR274","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/vaccines2030601","volume":"2","author":"M Richter","year":"2014","unstructured":"Richter M, Mewes A, Fritsch M, Krugel U, Hoffmann R, Singer D (2014) Doubly phosphorylated peptide vaccines to protect transgenic P301S mice against Alzheimer's disease like tau aggregation. Vaccines 2:601\u2013623. https:\/\/doi.org\/10.3390\/vaccines2030601","journal-title":"Vaccines"},{"key":"664_CR275","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316:750\u2013754. https:\/\/doi.org\/10.1126\/science.1141736","journal-title":"Science"},{"key":"664_CR276","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1093\/hmg\/ddp264","volume":"18","author":"T Rodriguez-Martin","year":"2009","unstructured":"Rodriguez-Martin T, Anthony K, Garcia-Blanco MA, Mansfield SG, Anderton BH, Gallo JM (2009) Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing. Hum Mol Genet 18:3266\u20133273. https:\/\/doi.org\/10.1093\/hmg\/ddp264","journal-title":"Hum Mol Genet"},{"key":"664_CR277","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jnen\/63.9.911","volume":"63","author":"Y Saito","year":"2004","unstructured":"Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Murayama S (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911\u2013918","journal-title":"J Neuropathol Exp Neurol"},{"key":"664_CR278","doi-asserted-by":"publisher","first-page":"P1172","DOI":"10.1016\/j.jalz.2016.07.096","volume":"12","author":"S Sanabria Bohorquez","year":"2016","unstructured":"Sanabria Bohorquez S, Barret O, Tamagnan G, Alagille D, Marik J, Ayalon G, Bengtsson T, de Crespigny A, Jennings D, Seibyl JP, Marek K, Weimer R, Kerchner GA (2016) Evaluation of tau burden in a cross-sectional cohort of Alzheimer\u2019s disease subjects using [18F]GTP1 (Genentech tau probe 1). Alzheimers Dement 12:P1172. https:\/\/doi.org\/10.1016\/j.jalz.2016.07.096","journal-title":"Alzheimers Dement"},{"key":"664_CR279","unstructured":"Sanabria Bohorquez, S., et al., Kinetics of [18F]GTP (Genentech tau probe 1) in the basal ganglia of Alzheimer's disease patients and healthy controls, in Human Amyloid Imaging Meeting. 2017. p. 32"},{"key":"664_CR280","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A, Barker SJ, Foley AC, Thorpe JR, Serpell LC, Miller TM, Grinberg LT, Seeley WW, Diamond MI (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271\u20131288. https:\/\/doi.org\/10.1016\/j.neuron.2014.04.047","journal-title":"Neuron"},{"key":"664_CR281","doi-asserted-by":"publisher","first-page":"e0125614","DOI":"10.1371\/journal.pone.0125614","volume":"10","author":"S Sankaranarayanan","year":"2015","unstructured":"Sankaranarayanan S, Barten DM, Vana L, Devidze N, Yang L, Cadelina G, Hoque N, DeCarr L, Keenan S, Lin A, Cao Y, Snyder B, Zhang B, Nitla M, Hirschfeld G, Barrezueta N, Polson C, Wes P, Rangan VS, Cacace A, Albright CF, Meredith J Jr, Trojanowski JQ, Lee VM, Brunden KR, Ahlijanian M (2015) Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models. PLoS One 10:e0125614. https:\/\/doi.org\/10.1371\/journal.pone.0125614","journal-title":"PLoS One"},{"key":"664_CR282","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476\u2013481. https:\/\/doi.org\/10.1126\/science.1113694","journal-title":"Science"},{"key":"664_CR283","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/s0002-9440(10)65659-3","volume":"153","author":"N Sasaki","year":"1998","unstructured":"Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N et al (1998) Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 153:1149\u20131155. https:\/\/doi.org\/10.1016\/s0002-9440(10)65659-3","journal-title":"Am J Pathol"},{"key":"664_CR284","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.neuron.2018.04.035","volume":"98","author":"C Sato","year":"2018","unstructured":"Sato C, Barthelemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Jockel-Balsarotti J, Sullivan M, Crisp MJ, Kasten T, Kirmess KM, Kanaan NM, Yarasheski KE, Baker-Nigh A, Benzinger TLS, Miller TM, Karch CM, Bateman RJ (2018) Tau kinetics in neurons and the human central nervous system. Neuron 98:861\u2013864. https:\/\/doi.org\/10.1016\/j.neuron.2018.04.035","journal-title":"Neuron"},{"key":"664_CR285","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuron.2011.06.031","volume":"71","author":"S Saxena","year":"2011","unstructured":"Saxena S, Caroni P (2011) Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71:35\u201348. https:\/\/doi.org\/10.1016\/j.neuron.2011.06.031","journal-title":"Neuron"},{"key":"664_CR286","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer's disease. Lancet 388:505\u2013517. https:\/\/doi.org\/10.1016\/s0140-6736(15)01124-1","journal-title":"Lancet"},{"key":"664_CR287","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuron.2016.04.042","volume":"90","author":"KM Schoch","year":"2016","unstructured":"Schoch KM, DeVos SL, Miller RL, Chun SJ, Norrbom M, Wozniak DF, Dawson HN, Bennett CF, Rigo F, Miller TM (2016) Increased 4R-tau induces pathological changes in a human-tau mouse model. Neuron 90:941\u2013947. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.042","journal-title":"Neuron"},{"key":"664_CR288","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ (2016) PET imaging of tau deposition in the aging human brain. Neuron 89:971\u2013982. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.028","journal-title":"Neuron"},{"key":"664_CR289","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/brain\/awx171","volume":"140","author":"M Sch\u00f6ll","year":"2017","unstructured":"Sch\u00f6ll M, Ossenkoppele R, Strandberg O, Palmqvist S, Jogi J, Ohlsson T, Smith R, Hansson O (2017) Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease. Brain 140:2286\u20132294. https:\/\/doi.org\/10.1093\/brain\/awx171","journal-title":"Brain"},{"key":"664_CR290","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fnmol.2017.00447","volume":"10","author":"K Schwab","year":"2017","unstructured":"Schwab K, Frahm S, Horsley D, Rickard JE, Melis V, Goatman EA, Magbagbeolu M, Douglas M, Leith MG, Baddeley TC, Storey JMD, Riedel G, Wischik CM, Harrington CR, Theuring F (2017) A protein aggregation inhibitor, Leuco-Methylthioninium Bis (Hydromethanesulfonate), decreases alpha-Synuclein inclusions in a transgenic mouse model of Synucleinopathy. Front Mol Neurosci 10:447. https:\/\/doi.org\/10.3389\/fnmol.2017.00447","journal-title":"Front Mol Neurosci"},{"key":"664_CR291","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/aww023","volume":"139","author":"AJ Schwarz","year":"2016","unstructured":"Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M, Joshi AD, Devous MD Sr, Mintun MS (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Brain 139:1539\u20131550. https:\/\/doi.org\/10.1093\/brain\/aww023","journal-title":"Brain"},{"key":"664_CR292","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"664_CR293","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jamaneurol.2017.0263","volume":"74","author":"J Sepulcre","year":"2017","unstructured":"Sepulcre J, Grothe MJ, Sabuncu M, Chhatwal J, Schultz AP, Hanseeuw B, El Fakhri G, Sperling R, Johnson KA (2017) Hierarchical Organization of tau and Amyloid Deposits in the cerebral cortex. JAMA Neurol 74:813\u2013820. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0263","journal-title":"JAMA Neurol"},{"key":"664_CR294","doi-asserted-by":"publisher","first-page":"7364","DOI":"10.1523\/jneurosci.0639-16.2016","volume":"36","author":"J Sepulcre","year":"2016","unstructured":"Sepulcre J, Schultz AP, Sabuncu M, Gomez-Isla T, Chhatwal J, Becker A, Sperling R, Johnson KA (2016) In vivo tau, amyloid, and gray matter profiles in the aging brain. J Neurosci 36:7364\u20137374. https:\/\/doi.org\/10.1523\/jneurosci.0639-16.2016","journal-title":"J Neurosci"},{"key":"664_CR295","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1046\/j.1471-4159.1997.69020834.x","volume":"69","author":"N Sergeant","year":"1997","unstructured":"Sergeant N, David JP, Goedert M, Jakes R, Vermersch P, Buee L, Lefranc D, Wattez A, Delacourte A (1997) Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications. J Neurochem 69:834\u2013844","journal-title":"J Neurochem"},{"key":"664_CR296","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","volume":"1739","author":"N Sergeant","year":"2005","unstructured":"Sergeant N, Delacourte A, Buee L (2005) Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739:179\u2013197. https:\/\/doi.org\/10.1016\/j.bbadis.2004.06.020","journal-title":"Biochim Biophys Acta"},{"key":"664_CR297","volume-title":"Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases","author":"N Sergeant","year":"2006","unstructured":"Sergeant N, Delacourte A, Melnyk P, Bu\u00e9e L (2006) Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases"},{"key":"664_CR298","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1038\/ncomms8025","volume":"6","author":"SL Shammas","year":"2015","unstructured":"Shammas SL, Garcia GA, Kumar S, Kjaergaard M, Horrocks MH, Shivji N, Mandelkow E, Knowles TP, Mandelkow E, Klenerman D (2015) A mechanistic model of tau amyloid aggregation based on direct observation of oligomers. Nat Commun 6:7025. https:\/\/doi.org\/10.1038\/ncomms8025","journal-title":"Nat Commun"},{"key":"664_CR299","doi-asserted-by":"publisher","first-page":"P146","DOI":"10.1016\/j.jalz.2017.06.2573","volume":"13","author":"H Shimada","year":"2017","unstructured":"Shimada H, Kitamura S, Ono M, Kimura Y, Ichise M, Takahata K, Moriguchi S, Kubota M, Ishii T, Takado Y, Seki C, Hirano S, Shinotoh H, Sahara N, Tempest P, Tamagnan G, Seibyl J, Barret O, Alagille D, Zhang M-R, Kuwabara S, Jang M-K, Marek K, Suhara T, Higuchi M (2017) FIRST-IN-HUMAN PET STUDY WITH <sup>18<\/sup>F-AM-PBB3 AND <sup>18<\/sup>F-PM-PBB3. Alzheimers Dement 13:P146. https:\/\/doi.org\/10.1016\/j.jalz.2017.06.2573","journal-title":"Alzheimers Dement"},{"key":"664_CR300","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0006-8993(96)00717-2","volume":"737","author":"RA Shiurba","year":"1996","unstructured":"Shiurba RA, Ishiguro K, Takahashi M, Sato K, Spooner ET, Mercken M, Yoshida R, Wheelock TR, Yanagawa H, Imahori K, Nixon RA (1996) Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology. Brain Res 737:119\u2013132","journal-title":"Brain Res"},{"key":"664_CR301","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000440842","volume":"16","author":"EM Sigurdsson","year":"2016","unstructured":"Sigurdsson EM (2016) Tau immunotherapy. Neurodegener Dis 16:34\u201338. https:\/\/doi.org\/10.1159\/000440842","journal-title":"Neurodegener Dis"},{"key":"664_CR302","doi-asserted-by":"publisher","first-page":"S555","DOI":"10.3233\/jad-179937","volume":"64","author":"EM Sigurdsson","year":"2018","unstructured":"Sigurdsson EM (2018) Tau immunotherapies for Alzheimer's disease and related Tauopathies: Progress and potential pitfalls. J Alzheimers Dis 64:S555\u2013s565. https:\/\/doi.org\/10.3233\/jad-179937","journal-title":"J Alzheimers Dis"},{"key":"664_CR303","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biom6010006","volume":"6","author":"G Simic","year":"2016","unstructured":"Simic G, Babic Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milosevic N, Bazadona D, Buee L, de Silva R, Di Giovanni G, Wischik C, Hof PR (2016) Tau protein hyperphosphorylation and aggregation in Alzheimer's disease and other Tauopathies, and possible neuroprotective strategies. Biomolecules 6:6. https:\/\/doi.org\/10.3390\/biom6010006","journal-title":"Biomolecules"},{"key":"664_CR304","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000334915","volume":"10","author":"D Simon","year":"2012","unstructured":"Simon D, Garcia-Garcia E, Gomez-Ramos A, Falcon-Perez JM, Diaz-Hernandez M, Hernandez F, Avila J (2012) Tau overexpression results in its secretion via membrane vesicles. Neurodegener Dis 10:73\u201375. https:\/\/doi.org\/10.1159\/000334915","journal-title":"Neurodegener Dis"},{"key":"664_CR305","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jalz.2017.07.347","volume":"13","author":"R Simone","year":"2017","unstructured":"Simone R (2017) Antisense long non-coding RNA represses MAPT translation through an embedded MIR repeat. Alzheimers Dement 13:918","journal-title":"Alzheimers Dement"},{"key":"664_CR306","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41:1308\u20131312. https:\/\/doi.org\/10.1038\/ng.487","journal-title":"Nat Genet"},{"key":"664_CR307","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/mcb.26.4.1333-1346.2006","volume":"26","author":"NK Singh","year":"2006","unstructured":"Singh NK, Singh NN, Androphy EJ, Singh RN (2006) Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26:1333\u20131346. https:\/\/doi.org\/10.1128\/mcb.26.4.1333-1346.2006","journal-title":"Mol Cell Biol"},{"key":"664_CR308","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10571-006-9083-3","volume":"26","author":"R Skrabana","year":"2006","unstructured":"Skrabana R, Sevcik J, Novak M (2006) Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis. Cell Mol Neurobiol 26:1085\u20131097. https:\/\/doi.org\/10.1007\/s10571-006-9083-3","journal-title":"Cell Mol Neurobiol"},{"key":"664_CR309","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/brain\/aww163","volume":"139","author":"R Smith","year":"2016","unstructured":"Smith R, Puschmann A, Sch\u00f6ll M, Ohlsson T, van Swieten J, Honer M, Englund E, Hansson O (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372\u20132379. https:\/\/doi.org\/10.1093\/brain\/aww163","journal-title":"Brain"},{"key":"664_CR310","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0489-6","volume":"5","author":"I Sotiropoulos","year":"2017","unstructured":"Sotiropoulos I, Galas MC, Silva JM, Skoulakis E, Wegmann S, Maina MB, Blum D, Sayas CL, Mandelkow EM, Mandelkow E, Spillantini MG, Sousa N, Avila J, Medina M, Mudher A, Buee L (2017) Atypical, non-standard functions of the microtubule associated tau protein. Acta Neuropathol Commun 5:91. https:\/\/doi.org\/10.1186\/s40478-017-0489-6","journal-title":"Acta Neuropathol Commun"},{"key":"664_CR311","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2967\/jnumed.117.200006","volume":"59","author":"S Southekal","year":"2018","unstructured":"Southekal S, Devous MD Sr, Kennedy I, Navitsky M, Lu M, Joshi AD, Pontecorvo MJ, Mintun MA (2018) Flortaucipir F 18 quantitation using parametric estimation of Reference signal intensity. J Nucl Med 59:944\u2013951. https:\/\/doi.org\/10.2967\/jnumed.117.200006","journal-title":"J Nucl Med"},{"key":"664_CR312","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/s1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609\u2013622. https:\/\/doi.org\/10.1016\/s1474-4422(13)70090-5","journal-title":"Lancet Neurol"},{"key":"664_CR313","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1073\/pnas.95.13.7737","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95:7737\u20137741","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR314","unstructured":"Stephens A, Seibyl JP, Mueller A, Barret O, Berndt M, Madonia J, et al. Clinical Update: [18F]PI-2620, a next generation Tau PET agent evaluated in subjects with Alzheimer's disease and progressive supranuclear palsy. Alzheimer's Association International Conference (2018), p. 24827"},{"key":"664_CR315","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nchem.2754","volume":"9","author":"J St\u00f6hr","year":"2017","unstructured":"St\u00f6hr J, Wu H, Nick M, Wu Y, Bhate M, Condello C, Johnson N, Rodgers J, Lemmin T, Acharya S, Becker J, Robinson K, Kelly MJS, Gai F, Stubbs G, Prusiner SB, DeGrado WF (2017) A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells. Nat Chem 9:874\u2013881. https:\/\/doi.org\/10.1038\/nchem.2754","journal-title":"Nat Chem"},{"key":"664_CR316","doi-asserted-by":"publisher","unstructured":"Sultan A, Nesslany F, Violet M, Begard S, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buee L, Galas MC (2011) Nuclear tau, a key player in neuronal DNA protection. J Biol Chem 286:4566\u20134575. https:\/\/doi.org\/10.1074\/jbc.M110.199976","DOI":"10.1074\/jbc.M110.199976"},{"key":"664_CR317","doi-asserted-by":"crossref","unstructured":"Tabrizi S, Leavitt B, Kordasiewicz H, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schobel S, Smith A et al (2018) Effects of IONIS-HTTRx in Patients with Early Huntington\u2019s Disease, Results of the First HTT-Lowering Drug Trial (CT.002). Neurology 90","DOI":"10.1212\/WNL.90.15_supplement.CT.002"},{"key":"664_CR318","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1083\/jcb.150.5.989","volume":"150","author":"Y Takei","year":"2000","unstructured":"Takei Y, Teng J, Harada A, Hirokawa N (2000) Defects in axonal elongation and neuronal migration in mice with disrupted tau and map 1b genes. J Cell Biol 150:989\u20131000","journal-title":"J Cell Biol"},{"key":"664_CR319","doi-asserted-by":"publisher","unstructured":"Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280:7614\u20137623. https:\/\/doi.org\/10.1074\/jbc.M408714200","DOI":"10.1074\/jbc.M408714200"},{"key":"664_CR320","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"664_CR321","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-160695","volume":"56","author":"C Theunis","year":"2017","unstructured":"Theunis C, Adolfsson O, Crespo-Biel N, Piorkowska K, Pihlgren M, Hickman DT, Gafner V, Borghgraef P, Devijver H, Pfeifer A, Van Leuven F, Muhs A (2017) Novel Phospho-tau monoclonal antibody generated using a liposomal vaccine, with enhanced recognition of a conformational Tauopathy epitope. J Alzheimers Dis 56:585\u2013599. https:\/\/doi.org\/10.3233\/JAD-160695","journal-title":"J Alzheimers Dis"},{"key":"664_CR322","doi-asserted-by":"publisher","first-page":"e72301","DOI":"10.1371\/journal.pone.0072301","volume":"8","author":"C Theunis","year":"2013","unstructured":"Theunis C, Crespo-Biel N, Gafner V, Pihlgren M, Lopez-Deber MP, Reis P, Hickman DT, Adolfsson O, Chuard N, Ndao DM, Borghgraef P, Devijver H, Van Leuven F, Pfeifer A, Muhs A (2013) Efficacy and safety of a liposome-based vaccine against protein tau, assessed in tau. P301L mice that model tauopathy. PLoS One 8:e72301. https:\/\/doi.org\/10.1371\/journal.pone.0072301","journal-title":"PLoS One"},{"key":"664_CR323","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1523\/jneurosci.4674-06.2007","volume":"27","author":"E Thies","year":"2007","unstructured":"Thies E, Mandelkow EM (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2\/Par-1. J Neurosci 27:2896\u20132907. https:\/\/doi.org\/10.1523\/jneurosci.4674-06.2007","journal-title":"J Neurosci"},{"key":"664_CR324","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s0072-9752(07)01251-1","volume":"89","author":"M Tolnay","year":"2008","unstructured":"Tolnay M, Probst A (2008) Argyrophilic grain disease. Handb Clin Neurol 89:553\u2013563. https:\/\/doi.org\/10.1016\/s0072-9752(07)01251-1","journal-title":"Handb Clin Neurol"},{"key":"664_CR325","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/brain\/awx046","volume":"140","author":"D Tosun","year":"2017","unstructured":"Tosun D, Landau S, Aisen PS, Petersen RC, Mintun M, Jagust W, Weiner MW (2017) Association between tau deposition and antecedent amyloid-beta accumulation rates in normal and early symptomatic individuals. Brain 140:1499\u20131512. https:\/\/doi.org\/10.1093\/brain\/awx046","journal-title":"Brain"},{"key":"664_CR326","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/156720512800492503","volume":"9","author":"L Troquier","year":"2012","unstructured":"Troquier L, Caillierez R, Burnouf S, Fernandez-Gomez FJ, Grosjean ME, Zommer N, Sergeant N, Schraen-Maschke S, Blum D, Buee L (2012) Targeting phospho-Ser422 by active tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res 9:397\u2013405","journal-title":"Curr Alzheimer Res"},{"key":"664_CR327","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2017.10.002","volume":"62","author":"S Tsartsalis","year":"2018","unstructured":"Tsartsalis S, Xekardaki A, Hof PR, Kovari E, Bouras C (2018) Early Alzheimer-type lesions in cognitively normal subjects. Neurobiol Aging 62:34\u201344. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.10.002","journal-title":"Neurobiol Aging"},{"key":"664_CR328","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/acn3.171","volume":"2","author":"T Umeda","year":"2015","unstructured":"Umeda T, Eguchi H, Kunori Y, Matsumoto Y, Taniguchi T, Mori H, Tomiyama T (2015) Passive immunotherapy of tauopathy targeting pSer413-tau: a pilot study in mice. Ann Clin Transl Neurol 2:241\u2013255. https:\/\/doi.org\/10.1002\/acn3.171","journal-title":"Ann Clin Transl Neurol"},{"key":"664_CR329","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1110\/ps.4210102","volume":"11","author":"VN Uversky","year":"2002","unstructured":"Uversky VN (2002) Natively unfolded proteins: a point where biology waits for physics. Protein Sci 11:739\u2013756. https:\/\/doi.org\/10.1110\/ps.4210102","journal-title":"Protein Sci"},{"key":"664_CR330","doi-asserted-by":"publisher","first-page":"e0163236","DOI":"10.1371\/journal.pone.0163236","volume":"11","author":"A Hummel van","year":"2016","unstructured":"van Hummel A, Bi M, Ippati S, van der Hoven J, Volkerling A, Lee WS, Tan DC, Bongers A, Ittner A, Ke YD, Ittner LM (2016) No overt deficits in aged tau-deficient C57Bl\/6.Mapttm1(EGFP) kit GFP Knockin mice. PLoS One 11:e0163236. https:\/\/doi.org\/10.1371\/journal.pone.0163236","journal-title":"PLoS One"},{"key":"664_CR331","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3233\/jad-180404","volume":"65","author":"M Vandermeeren","year":"2018","unstructured":"Vandermeeren M, Borgers M, Van Kolen K, Theunis C, Vasconcelos B, Bottelbergs A, Wintmolders C, Daneels G, Willems R, Dockx K, Delbroek L, Marreiro A, Ver Donck L, Sousa C, Nanjunda R, Lacy E, Van De Casteele T, Van Dam D, De Deyn PP, Kemp JA, Malia TJ, Mercken MH (2018) Anti-tau monoclonal antibodies derived from soluble and filamentous tau show diverse functional properties in vitro and in vivo. J Alzheimers Dis 65:265\u2013281. https:\/\/doi.org\/10.3233\/jad-180404","journal-title":"J Alzheimers Dis"},{"key":"664_CR332","doi-asserted-by":"publisher","unstructured":"Velazquez R, Ferreira E, Tran A, Turner EC, Belfiore R, Branca C, Oddo S (2018) Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits. Aging Cell:e12775. https:\/\/doi.org\/10.1111\/acel.12775","DOI":"10.1111\/acel.12775"},{"key":"664_CR333","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.dadm.2016.12.010","volume":"6","author":"P Vemuri","year":"2017","unstructured":"Vemuri P, Lowe VJ, Knopman DS, Senjem ML, Kemp BJ, Schwarz CG, Przybelski SA, Machulda MM, Petersen RC, Jack CR Jr (2017) Tau-PET uptake: regional variation in average SUVR and impact of amyloid deposition. Alzheimers Dement (Amst) 6:21\u201330. https:\/\/doi.org\/10.1016\/j.dadm.2016.12.010","journal-title":"Alzheimers Dement (Amst)"},{"key":"664_CR334","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/jphp.12919","volume":"70","author":"S Verma","year":"2018","unstructured":"Verma S, Kumar A, Tripathi T, Kumar A (2018) Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy. J Pharm Pharmacol 70:985\u2013993. https:\/\/doi.org\/10.1111\/jphp.12919","journal-title":"J Pharm Pharmacol"},{"key":"664_CR335","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mds.27271","volume":"33","author":"C Vermeiren","year":"2018","unstructured":"Vermeiren C, Motte P, Viot D, Mairet-Coello G, Courade JP, Citron M, Mercier J, Hannestad J, Gillard M (2018) The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases. Mov Disord 33:273\u2013281. https:\/\/doi.org\/10.1002\/mds.27271","journal-title":"Mov Disord"},{"key":"664_CR336","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.neuron.2018.05.027","volume":"98","author":"S Vijayraghavan","year":"2018","unstructured":"Vijayraghavan S, Major AJ, Everling S (2018) Muscarinic M1 receptor overstimulation disrupts working memory activity for rules in primate prefrontal cortex. Neuron 98:1256\u20131268.e1254. https:\/\/doi.org\/10.1016\/j.neuron.2018.05.027","journal-title":"Neuron"},{"key":"664_CR337","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fncel.2014.00084","volume":"8","author":"M Violet","year":"2014","unstructured":"Violet M, Delattre L, Tardivel M, Sultan A, Chauderlier A, Caillierez R, Talahari S, Nesslany F, Lefebvre B, Bonnefoy E, Buee L, Galas MC (2014) A major role for tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions. Front Cell Neurosci 8:84. https:\/\/doi.org\/10.3389\/fncel.2014.00084","journal-title":"Front Cell Neurosci"},{"key":"664_CR338","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbadis.2004.09.010","volume":"1739","author":"M Bergen von","year":"2005","unstructured":"von Bergen M, Barghorn S, Biernat J, Mandelkow EM, Mandelkow E (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta 1739:158\u2013166. https:\/\/doi.org\/10.1016\/j.bbadis.2004.09.010","journal-title":"Biochim Biophys Acta"},{"key":"664_CR339","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","volume":"97","author":"M Bergen von","year":"2000","unstructured":"von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A 97:5129\u20135134","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR340","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/13554790590944825","volume":"11","author":"A Gunten von","year":"2005","unstructured":"von Gunten A, Miklossy J, Suva ML, Hof PR, Glannakopoulos P (2005) Environmental reduplicative paramnesia in a case of atypical Alzheimer's disease. Neurocase 11:216\u2013226. https:\/\/doi.org\/10.1080\/13554790590944825","journal-title":"Neurocase"},{"key":"664_CR341","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.201407065","volume":"209","author":"KA Vossel","year":"2015","unstructured":"Vossel KA, Xu JC, Fomenko V, Miyamoto T, Suberbielle E, Knox JA, Ho K, Kim DH, Yu GQ, Mucke L (2015) Tau reduction prevents Abeta-induced axonal transport deficits by blocking activation of GSK3beta. J Cell Biol 209:419\u2013433. https:\/\/doi.org\/10.1083\/jcb.201407065","journal-title":"J Cell Biol"},{"key":"664_CR342","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neulet.2014.05.047","volume":"575","author":"KC Walls","year":"2014","unstructured":"Walls KC, Ager RR, Vasilevko V, Cheng D, Medeiros R, LaFerla FM (2014) P-tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice. Neurosci Lett 575:96\u2013100. https:\/\/doi.org\/10.1016\/j.neulet.2014.05.047","journal-title":"Neurosci Lett"},{"key":"664_CR343","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm0896-871","volume":"2","author":"JZ Wang","year":"1996","unstructured":"Wang JZ, Grundke-Iqbal I, Iqbal K (1996) Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Nat Med 2:871\u2013875","journal-title":"Nat Med"},{"key":"664_CR344","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","volume":"73","author":"L Wang","year":"2016","unstructured":"Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC, Ances BM (2016) Evaluation of tau imaging in staging Alzheimer disease and revealing interactions between beta-amyloid and Tauopathy. JAMA Neurol 73:1070\u20131077. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2078","journal-title":"JAMA Neurol"},{"key":"664_CR345","doi-asserted-by":"publisher","first-page":"e0195486","DOI":"10.1371\/journal.pone.0195486","volume":"13","author":"X Wang","year":"2018","unstructured":"Wang X, Smith K, Pearson M, Hughes A, Cosden ML, Marcus J, Hess JF, Savage MJ, Rosahl T, Smith SM, Schachter JB, Uslaner JM (2018) Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy. PLoS One 13:e0195486. https:\/\/doi.org\/10.1371\/journal.pone.0195486","journal-title":"PLoS One"},{"key":"664_CR346","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y, Balaji V, Kaniyappan S, Kruger L, Irsen S, Tepper K, Chandupatla R, Maetzler W, Schneider A, Mandelkow E, Mandelkow EM (2017) The release and trans-synaptic transmission of tau via exosomes. Mol Neurodegener 12:5. https:\/\/doi.org\/10.1186\/s13024-016-0143-y","journal-title":"Mol Neurodegener"},{"key":"664_CR347","doi-asserted-by":"publisher","unstructured":"Wanowska E, Kubiak MR, Rosikiewicz W, Makalowska I, Szczesniak MW (2018) Natural antisense transcripts in diseases: from modes of action to targeted therapies. Wiley Interdiscip Rev RNA 9. https:\/\/doi.org\/10.1002\/wrna.1461","DOI":"10.1002\/wrna.1461"},{"key":"664_CR348","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0197-4580(00)00157-3","volume":"21","author":"CL Weaver","year":"2000","unstructured":"Weaver CL, Espinoza M, Kress Y, Davies P (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging 21:719\u2013727","journal-title":"Neurobiol Aging"},{"key":"664_CR349","doi-asserted-by":"publisher","first-page":"e2600","DOI":"10.1371\/journal.pone.0002600","volume":"3","author":"Y Wei","year":"2008","unstructured":"Wei Y, Qu MH, Wang XS, Chen L, Wang DL, Liu Y, Hua Q, He RQ (2008) Binding to the minor groove of the double-strand, tau protein prevents DNA from damage by peroxidation. PLoS One 3:e2600. https:\/\/doi.org\/10.1371\/journal.pone.0002600","journal-title":"PLoS One"},{"key":"664_CR350","first-page":"91","volume-title":"Human Amyloid Imaging Meeting","author":"R Weimer","year":"2017","unstructured":"Weimer R et al (2017) Evaluation of baseline and longitudinal tau burden in Alzheimer's disease using [18F]GTP1 (Genentech Tau Probe 1) PET imaging. In: Human Amyloid Imaging Meeting, p 91"},{"key":"664_CR351","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858\u20131862","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR352","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ana.25142","volume":"83","author":"JL Whitwell","year":"2018","unstructured":"Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Schwarz CG, Spychalla AJ, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, Jack CR Jr, Josephs KA (2018) [(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease. Ann Neurol 83:248\u2013257. https:\/\/doi.org\/10.1002\/ana.25142","journal-title":"Ann Neurol"},{"key":"664_CR353","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/alzrt237","volume":"6","author":"B Winblad","year":"2014","unstructured":"Winblad B, Graf A, Riviere ME, Andreasen N, Ryan JM (2014) Active immunotherapy options for Alzheimer's disease. Alzheimers Res Ther 6:7. https:\/\/doi.org\/10.1186\/alzrt237","journal-title":"Alzheimers Res Ther"},{"key":"664_CR354","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","volume":"75","author":"JR Winer","year":"2018","unstructured":"Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ (2018) Associations between tau, beta-amyloid, and cognition in Parkinson disease. JAMA Neurol 75:227\u2013235. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3713","journal-title":"JAMA Neurol"},{"key":"664_CR355","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","volume":"93","author":"CM Wischik","year":"1996","unstructured":"Wischik CM, Edwards PC, Lai RY, Roth M, Harrington CR (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A 93:11213\u201311218","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR356","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","volume":"88","author":"CM Wischik","year":"2014","unstructured":"Wischik CM, Harrington CR, Storey JM (2014) Tau-aggregation inhibitor therapy for Alzheimer's disease. Biochem Pharmacol 88:529\u2013539. https:\/\/doi.org\/10.1016\/j.bcp.2013.12.008","journal-title":"Biochem Pharmacol"},{"key":"664_CR357","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1073\/pnas.85.13.4884","volume":"85","author":"CM Wischik","year":"1988","unstructured":"Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, Crowther RA (1988) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85:4884\u20134888","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR358","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","volume":"85","author":"CM Wischik","year":"1988","unstructured":"Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R et al (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85:4506\u20134510","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR359","doi-asserted-by":"publisher","unstructured":"Wong DF, Comley R, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, Vozzi C, Boess F, Oh E, Lyketsos CG, Honer M, Gobbi L, Klein G, George N, Gapasin L, Kitzmiller K, Roberts J, Sevigny J, Nandi A, Brasic JR, Mishra C, Thambisetty M, Moghekar A, Mathur A, Albert M, Dannals RF, Borroni E (2018) First in-human PET study of 3 novel tau radiopharmaceuticals: [(11)C]RO6924963, [(11)C]RO6931643, and [(18)F]RO6958948. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.118.209916","DOI":"10.2967\/jnumed.118.209916"},{"key":"664_CR360","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1073\/pnas.83.11.4040","volume":"83","author":"JG Wood","year":"1986","unstructured":"Wood JG, Mirra SS, Pollock NJ, Binder LI (1986) Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci U S A 83:4040\u20134043","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR361","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0535-z","volume":"6","author":"MC Wren","year":"2018","unstructured":"Wren MC, Lashley T, Arstad E, Sander K (2018) Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias. Acta Neuropathol Commun 6:34. https:\/\/doi.org\/10.1186\/s40478-018-0535-z","journal-title":"Acta Neuropathol Commun"},{"key":"664_CR362","doi-asserted-by":"publisher","unstructured":"Wu JW, Herman M, Liu L, Simoes S, Acker CM, Figueroa H, Steinberg JI, Margittai M, Kayed R, Zurzolo C, Di Paolo G, Duff KE (2013) Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem 288:1856\u20131870. https:\/\/doi.org\/10.1074\/jbc.M112.394528","DOI":"10.1074\/jbc.M112.394528"},{"key":"664_CR363","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K, Sanders DW, Cook C, Fu H, Boonen RA, Herman M, Nahmani E, Emrani S, Figueroa YH, Diamond MI, Clelland CL, Wray S, Duff KE (2016) Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci 19:1085\u20131092. https:\/\/doi.org\/10.1038\/nn.4328","journal-title":"Nat Neurosci"},{"key":"664_CR364","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejps.2017.03.037","volume":"110","author":"X Wu","year":"2017","unstructured":"Wu X, Kosaraju J, Tam KY (2017) SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3beta activity in SH-SY5Y cells. Eur J Pharm Sci 110:101\u2013108. https:\/\/doi.org\/10.1016\/j.ejps.2017.03.037","journal-title":"Eur J Pharm Sci"},{"key":"664_CR365","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neulet.2018.09.056","volume":"687","author":"X Wu","year":"2018","unstructured":"Wu X, Kosaraju J, Tam KY (2018) Anti-neuroinflammatory effects of SLOH in Abeta-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3beta. Neurosci Lett 687:207\u2013215. https:\/\/doi.org\/10.1016\/j.neulet.2018.09.056","journal-title":"Neurosci Lett"},{"key":"664_CR366","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.neuropharm.2018.01.003","volume":"131","author":"X Wu","year":"2018","unstructured":"Wu X, Kosaraju J, Zhou W, Tam KY (2018) SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Neuropharmacology 131:351\u2013363. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.003","journal-title":"Neuropharmacology"},{"key":"664_CR367","doi-asserted-by":"publisher","first-page":"175628641877693","DOI":"10.1177\/1756286418776932","volume":"11","author":"CD Wurster","year":"2018","unstructured":"Wurster CD, Ludolph AC (2018) Antisense oligonucleotides in neurological disorders. Ther Adv Neurol Disord 11:1756286418776932. https:\/\/doi.org\/10.1177\/1756286418776932","journal-title":"Ther Adv Neurol Disord"},{"key":"664_CR368","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamaneurol.2016.5755","volume":"74","author":"C Xia","year":"2017","unstructured":"Xia C, Makaretz SJ, Caso C, McGinnis S, Gomperts SN, Sepulcre J, Gomez-Isla T, Hyman BT, Schultz A, Vasdev N, Johnson KA, Dickerson BC (2017) Association of in Vivo [18F]AV-1451 tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease. JAMA Neurol 74:427\u2013436. https:\/\/doi.org\/10.1001\/jamaneurol.2016.5755","journal-title":"JAMA Neurol"},{"key":"664_CR369","doi-asserted-by":"publisher","first-page":"34363","DOI":"10.1038\/srep34363","volume":"6","author":"M Yagi","year":"2016","unstructured":"Yagi M, Palacpac NM, Ito K, Oishi Y, Itagaki S, Balikagala B, Ntege EH, Yeka A, Kanoi BN, Katuro O, Shirai H, Fukushima W, Hirota Y, Egwang TG, Horii T (2016) Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda. Sci Rep 6:34363. https:\/\/doi.org\/10.1038\/srep34363","journal-title":"Sci Rep"},{"key":"664_CR370","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1523\/jneurosci.2569-11.2011","volume":"31","author":"K Yamada","year":"2011","unstructured":"Yamada K, Cirrito JR, Stewart FR, Jiang H, Finn MB, Holmes BB, Binder LI, Mandelkow EM, Diamond MI, Lee VM, Holtzman DM (2011) In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci 31:13110\u201313117. https:\/\/doi.org\/10.1523\/jneurosci.2569-11.2011","journal-title":"J Neurosci"},{"key":"664_CR371","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, Cirrito JR, Patel TK, Hochgrafe K, Mandelkow EM, Holtzman DM (2014) Neuronal activity regulates extracellular tau in vivo. J Exp Med 211:387\u2013393. https:\/\/doi.org\/10.1084\/jem.20131685","journal-title":"J Exp Med"},{"key":"664_CR372","doi-asserted-by":"publisher","unstructured":"Yamada M, Hamaguchi T (2018) The sulfation code for propagation of neurodegeneration. J Biol Chem 293:10841\u201310842. https:\/\/doi.org\/10.1074\/jbc.H118.003970","DOI":"10.1074\/jbc.H118.003970"},{"key":"664_CR373","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.1073\/pnas.91.16.7787","volume":"91","author":"SD Yan","year":"1994","unstructured":"Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS et al (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci U S A 91:7787\u20137791","journal-title":"Proc Natl Acad Sci U S A"},{"key":"664_CR374","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/acn3.176","volume":"2","author":"K Yanamandra","year":"2015","unstructured":"Yanamandra K, Jiang H, Mahan TE, Maloney SE, Wozniak DF, Diamond MI, Holtzman DM (2015) Anti-tau antibody reduces insoluble tau and decreases brain atrophy. Ann Clin Transl Neurol 2:278\u2013288. https:\/\/doi.org\/10.1002\/acn3.176","journal-title":"Ann Clin Transl Neurol"},{"key":"664_CR375","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K, Kfoury N, Jiang H, Mahan TE, Ma S, Maloney SE, Wozniak DF, Diamond MI, Holtzman DM (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80:402\u2013414. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.046","journal-title":"Neuron"},{"key":"664_CR376","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang X, Qian K (2017) Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol 18:452\u2013465. https:\/\/doi.org\/10.1038\/nrm.2017.22","journal-title":"Nat Rev Mol Cell Biol"},{"key":"664_CR377","doi-asserted-by":"publisher","first-page":"e35277","DOI":"10.1371\/journal.pone.0035277","volume":"7","author":"Y Yu","year":"2012","unstructured":"Yu Y, Zhang L, Li X, Run X, Liang Z, Li Y et al (2012) Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation. PLoS One 7:e35277. https:\/\/doi.org\/10.1371\/journal.pone.0035277","journal-title":"PLoS One"},{"key":"664_CR378","doi-asserted-by":"publisher","first-page":"e2002183","DOI":"10.1371\/journal.pbio.2002183","volume":"15","author":"X Zhang","year":"2017","unstructured":"Zhang X, Lin Y, Eschmann NA, Zhou H, Rauch JN, Hernandez I et al (2017) RNA stores tau reversibly in complex coacervates. PLoS Biol 15:e2002183. https:\/\/doi.org\/10.1371\/journal.pbio.2002183","journal-title":"PLoS Biol"},{"key":"664_CR379","doi-asserted-by":"publisher","first-page":"16368","DOI":"10.1038\/s41598-017-16635-4","volume":"7","author":"W Zhou","year":"2017","unstructured":"Zhou W, Hu X, Tam KY (2017) Systemic clearance and brain distribution of carbazole-based cyanine compounds as Alzheimer's disease drug candidates. Sci Rep 7:16368. https:\/\/doi.org\/10.1038\/s41598-017-16635-4","journal-title":"Sci Rep"},{"key":"664_CR380","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnagi.2018.00027","volume":"10","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Shi J, Chu D, Hu W, Guan Z, Gong CX et al (2018) Relevance of phosphorylation and truncation of tau to the Etiopathogenesis of Alzheimer's disease. Front Aging Neurosci 10:27. https:\/\/doi.org\/10.3389\/fnagi.2018.00027","journal-title":"Front Aging Neurosci"},{"key":"664_CR381","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.febslet.2006.05.029","volume":"580","author":"N Zilka","year":"2006","unstructured":"Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, Novak M (2006) Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 580:3582\u20133588. https:\/\/doi.org\/10.1016\/j.febslet.2006.05.029","journal-title":"FEBS Lett"},{"key":"664_CR382","doi-asserted-by":"publisher","unstructured":"Zilka N, Kazmerova Z, Jadhav S, Neradil P, Madari A, Obetkova D, Bugos O, Novak M. Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways. J Neuroinflammation. 2012 Mar 7;9:47. https:\/\/doi.org\/10.1186\/1742-2094-9-47","DOI":"10.1186\/1742-2094-9-47"},{"key":"664_CR383","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00401-009-0499-y","volume":"118","author":"N Zilka","year":"2009","unstructured":"Zilka N, Korenova M, Novak M (2009) Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Acta Neuropathol 118:71\u201386. https:\/\/doi.org\/10.1007\/s00401-009-0499-y","journal-title":"Acta Neuropathol"},{"key":"664_CR384","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1042\/bst20120015","volume":"40","author":"N Zilka","year":"2012","unstructured":"Zilka N, Kovacech B, Barath P, Kontsekova E, Novak M (2012) The self-perpetuating tau truncation circle. Biochem Soc Trans 40:681\u2013686. https:\/\/doi.org\/10.1042\/bst20120015","journal-title":"Biochem Soc Trans"},{"key":"664_CR385","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3233\/jad-160347","volume":"54","author":"I Zimova","year":"2016","unstructured":"Zimova I, Brezovakova V, Hromadka T, Weisova P, Cubinkova V, Valachova B et al (2016) Human truncated tau induces mature neurofibrillary pathology in a mouse model of human Tauopathy. J Alzheimers Dis 54:831\u2013843. https:\/\/doi.org\/10.3233\/jad-160347","journal-title":"J Alzheimers Dis"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0664-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0664-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:32:49Z","timestamp":1720974769000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0664-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":385,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0664-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735100785.793568298","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"30 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SJ, RS, EK and NZ are Axon Neuroscience R&D Services employees. LB received research grants from UCB Biopharma. Other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"22"}}